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Abstract 
Traditional 2D cell culture protocols poorly represent in vivo conditions. Methods to allow 
culturing of patient derived cells in scaffolds that closely mimic the 3D environment would be of 
great clinical value. Parameters to consider are tissue stiffness, chemical and stiffness gradients, 
and the ability to co-culture various cell types. This project aimed to create a 3D hydrogel system 
in a range of stiffness comparable to body tissues while allowing cell growth and differentiation 
in a 3D environment. The design utilized a fast gelling hydrogel and a cross-linker that allowed 
controlled stiffness. This was combined with a microfluidic gradient generator to produce a 3D 
hydrogel with a continuous stiffness gradient. This approach can be a valuable tool for tissue 
engineering research. 
  
List of Figures 
Figure 2.1: Source Sink Diffusion ............................................................................................................................................................. 22 
Figure 2.2: Gradient Generator ................................................................................................................................................................ 23 
Figure 2.3: Dynamic Mixing ....................................................................................................................................................................... 23 
Figure 2.4: Convective Spreading............................................................................................................................................................. 24 
Figure 2.5: Measurement through Atomic Force Microscopy ........................................................................................................ 25 
Figure 3.1: Objective Tree ........................................................................................................................................................................... 28 
Figure 3.2: Work Breakdown Structure .................................................................................................................................................. 36 
Figure 4.1: Dynamic Mixing Sketch ......................................................................................................................................................... 42 
Figure 4.2: Gradient Generator Mold Sketch ....................................................................................................................................... 43 
Figure 4.3: Dynamic Flow Middle Sketch.............................................................................................................................................. 44 
Figure 4.4: Dynamic Flow Side Sketch ................................................................................................................................................... 44 
Figure 4.5: Radial Cross-linker Sketch ................................................................................................................................................... 45 
Figure 4.6: Vertical Diffusion Sketch ...................................................................................................................................................... 45 
Figure 4.7: 1.96 mM H2O2 Gelation Results ......................................................................................................................................... 56 
Figure 4.8: 1.47 mM H2O2 Gelation Results ......................................................................................................................................... 56 
Figure 4.9: 0.98mM H2O2 Gelation Results .......................................................................................................................................... 57 
Figure 4.10: Test gels for 1%, 1.5%, and 2% gelatin-HPA. ............................................................................................................ 60 
Figure 4.11: Gelation time data ................................................................................................................................................................ 60 
Figure 5.1: Average AFM Measurements for Gtn-HPA Hydrogels. ............................................................................................. 61 
Figure 5.2: Gradients generated with water and food dye ............................................................................................................... 62 
Figure 5.3: Cells Flowing through Gradient generator .................................................................................................................... 63 
Figure 5.4: Gelatin-HPA percentage and H2O2 concentration in each syringe ....................................................................... 64 
Figure 5.5: Gelatin-HPA with H2O2 Gradient Gel ranging from softer to stiffer .................................................................... 64 
Figure 5.6: Cells encapsulated within the 3D Hydrogel with a stiffness gradient ................................................................... 65 
Figure 5.7: Mouse Fibroblast cells (3T3) in 3D Gel .......................................................................................................................... 67 
Figure 5.8: Primary Human Fibroblast cells (2097 line) in 3D Gel ............................................................................................ 68 
Figure 5.9: Mouse embryonic fibroblast cell line (STO) in 3D gel ............................................................................................... 69 
Figure 6.1: Gel Conjugate Preparation Costs ...................................................................................................................................... 76 
Figure 6.2: Cost Analysis for the Creation of Gradient Gels .......................................................................................................... 76 
Figure 6.3: Cost Analysis for the Gradient Generator Creation ................................................................................................... 77 
Figure 7.1: Final Design Methods ............................................................................................................................................................ 78 
Figure 7.2: Syringe Pump Setup ................................................................................................................................................................ 81 
Figure 7.3: Gradient Illustration ............................................................................................................................................................... 81 
 
  
List of Tables 
Table 3.1: Pairwise Comparison Chart……………………………………………………………………………………...…29 
Table 3.2: Design Evaluation Matrix for Hydrogel Precursor……………………………………………………………...33 
Table 3.3: Design Evaluation Matrix for Cross-linking Reagent…………………………………………………………..34 
Table 3.4: Preliminary Design Evaluation Matrix for Gradient Generation Method…………………………………..35 
Table 4.1: Design Specifications…………….………………………………………………………………………………….41 
Table 4.2: Revised Design Evaluation Matrix for Gradient Generation Method…………….………………………….46 
Table 4.3: 1.5% Gelatin-HPA Hydrogels………………………………………………………………………………………51 
Table 4.4: 1.5% Gelatin-HPA Hydrogels (half volume)…………………………………………………………..…………54 
Table 4.5: Preliminary AFM Measurements……………………………………………………………………………….….57 
Table 4.6: Additional AFM Measurements…………………………………………………………………………………….58 
Table 4.7: Revised Gelatin-HPA Hydrogel Formula……………………………………………………………………...….58 
Table 4.8: Revised H2O2 Stock Solutions……………………………………………………………………………………....59 
Table 7.1: Gelatin-HPA Hydrogel Formulas.........................................................................................................…...79  
Table 7.2: H2O2 Stock Solutions…………………………………………………………………………………………...……79 
  
Chapter 1: Introduction 
Cell development and behavior is influenced by various chemical and mechanical stimuli. 
Growth factors, surface characteristics, loading conditions, biochemical factors, and stiffness are 
some of the many factors that affect cell behavior. Studies suggest that among these stiffness is 
one of the more selective factors (Mason et al., 2012; Breuls et al., 2008). Stiffness plays an 
important role in deciding cell morphology, differentiation, proliferation, and striation. A current 
challenge in cell culture is that most cell culture studies are performed under conditions that are 
unrepresentative of native tissue stiffness. 
The body exhibits a select range of stiffness: Brain tissue is one of the softest tissues, at 
approximately 0.1 to 1 kPa, while bone is one of the stiffest, at approximately 25 to 40 kPa (Tse 
and Engler, 2011). Cell culture is generally conducted using extremely stiff 2D polystyrene well 
plates that have two main limitations. First, these plates have a stiffness of 1 GPa, a value several 
magnitudes stiffer than what is experienced in vivo (Kolahi et al., 2012). Second, these plates are 
2D, which does not allow for the 3D cell growth, morphologies, and migration that occurs within 
the in vivo environment. To address these limitations, hydrogels are being developed to provide 
more realistic tissue-like environments. 
Hydrogels provide a highly hydrophilic environment similar to native tissue conditions and can 
be easily modified to possess specific mechanical properties. Hydrogel scaffolds are currently 
being engineered and used in research to study cell behavior at different stiffness levels. A novel 
approach to survey the effects of stiffness on cellular behavior in a 3D environment is the use of 
hydrogels containing continuous stiffness gradients. 
Various microfluidic techniques have been used to successfully create stiffness gradients in 3D 
hydrogels (Sant et al., 2010). However, these techniques are intended for cell seeding on the 
surface of the hydrogel for 2D culture. A major challenge in developing cell laden 3D hydrogels 
is the paucity of a combination of biomaterials and cross-linkers that allow fast gelation times 
(<10 minutes) to allow uniform cell distribution in 3D hydrogels. Moreover, most of the 
currently available methods for gradient generation depend on cross-linking reactions using 
exposure to UV light. 
In order to observe cell behavior most representative of cell behavior in vivo, an in vitro model 
needs to be developed that permits cells to experience natural levels of stiffness in a three-
dimensional environment. The goal of this project was to overcome current cell culture 
limitations by designing a three-dimensional, stiffness-gradient containing, cell-encapsulating 
hydrogel. This design combined the use of the Gelatin-Hydroxyphenylpropionic acid (Gelatin-
HPA) conjugate described by Wang et al. (2012) that gels rapidly, and a microfluidic gradient 
generator that produces a continuous gradient. The team formulated hydrogel precursors that 
enabled a stiffness gradient within the range of 300-1500 Pa. Once the design was completed, the 
gradient-hydrogels were tested and validated to ensure continuity and consistency of mechanical 
properties, as well as biocompatibility. Formation of a continuous gradient ranging within 300 to 
1500 Pa will more accurately represent natural in vivo stiffness, allowing for a variety of cell 
types to be evaluated along very specific increments of stiffness.  
This gradient-hydrogel can be used as an in vitro model for researchers to study how cells 
migrate, proliferate, and differentiate in response to different stiffness levels. The creation of an 
innovative three-dimensional cell encapsulating hydrogel with a stiffness gradient has the 
potential to revolutionize cell culture due to its many potential applications. This scaffold could 
allow for the co-culturing of cells to create more successful cell therapies, the creation of 
organoids for drug and device testing, and could provide a better simulation of an in vivo 
environment. With these many applications in mind, this gradient-hydrogel for cell encapsulation 
could serve as the basis for the future of biomedical research. 
 
 
  
Chapter 2: Background 
The goal of the project was to create a 3D hydrogel with a continuous stiffness gradient to allow 
cell behavior to be studied more accurately and advancements to be made in the field of tissue 
engineering. To assist in the understanding of this project, this chapter reviews topics such as the 
tissue engineering field, scaffolds, hydrogels, in vivo systems, and stiffness gradients. 
2.1 Tissue Engineering and Applications 
Tissue engineering is the creation of artificial human tissue in order to repair, replace or enhance 
the function of organs and tissues in the human body. Natural and synthetic materials are used to 
design scaffolds that aim to simulate the in vivo environment. These scaffolds can then be seeded 
with cells of interest and cultured into working tissues.   
Through tissue engineering, researchers aim to mimic native human tissue as closely as possible 
for a variety of applications. One such application is the engineering of cartilage tissue. Cartilage 
is naturally made up of type two collagen and glycosaminoglycans, and has a similar 
macromolecular structure to many natural and synthetic hydrogels. Hydrogel scaffolds have been 
developed with embedded chondrocytes and growth factors to stimulate the development of 
cartilage tissue, and many have been tested in vitro and in vivo (Drury and Mooney, 2003).  
Another application of tissue engineering scaffolds is the development of skin grafts for wound 
healing. In this application, a single layer or bi-layer ECM is produced and seeded with skin cells 
preferably patient-derived. Tissue engineered skin has successfully been developed to provide a 
barrier to the outside world, but more research is required to develop the complex functions such 
as temperature control through sweat glands and immune response through Langerhans cells 
(Metcalfe and Ferguson, 2007). Tissue engineering is an advancing field in biomedical research 
and regenerative medicine; however current methods are far from the ultimate goal of producing 
fully functioning organs. 
2.2 Scaffolds 
Scaffolds are important in tissue engineering because they act as a supportive matrix structure for 
the cells to grow in.  They can be made from a variety of different materials, allowing for a range 
of mechanical properties to be achieved. 
2.2.1 Properties 
There are many properties that can be determined depending on the type of scaffold material 
used. For example, the stiffness of the scaffold will affect how the cells proliferate and grow 
(Chan and Leong, 2008). Also, the cell adhesion of the scaffold can be modified depending on 
whether the cell line being used is highly anchorage-dependent or not. In addition, specific cells 
require more nutrients and factors than others, so it is important to change the vascularization 
and diffusivity of each scaffold in accordance with this need. Overall, scaffolds must be 
biocompatible so that they can promote the growth, proliferation, maturation, and migration of 
the cells (Chan and Leong, 2008). 
To tailor these properties, scaffolds can be made out of a variety of different materials. These 
materials fall under two categories, natural scaffold materials and synthetic scaffold materials. 
Natural Scaffold Materials 
Naturally occurring materials are one option for the creation of scaffolds. Natural materials 
include collagen, chitosan, fibrin, alginate, and many more. Natural materials are commonly 
used because of their high biocompatibility levels. In one specific example, a scaffold made of 
collagen and chitosan was created as a scaffold for tissue engineered skin. Since these natural 
materials are found in the body, the scaffold is biocompatible to both the cells in the engineered 
construct as well as in the body itself (Ma, 2004). 
Synthetic Scaffold Materials 
Synthetic materials are another option for the fabrication of scaffolds. Synthetic materials 
include HEMA, PEG, PGA, NIPAM, and a variety of others. Since these materials are fabricated 
in a lab, their properties can be easily manipulated. For example, P(NIPAM-HEMA) is a 
thermosensitive polymer (Gan et al., 2009). This means that the material is a solution when the 
temperature is below the Lower Critical Solution Temperature (LCST) and is a gel when it is 
above the LCST. One study used P(NIPAM-HEMA) as a cellular scaffold and drug delivery 
device by injecting it into the body. As it was injected, it became a gel because of its properties, 
allowing it to properly serve as a scaffold and drug delivery system (Gan et al., 2009). Many 
other synthetic materials can be altered or combined in similar ways to create materials with 
different properties. 
2.2.2 Importance of Environment 
It is important for a scaffold to possess certain properties in order to mimic an in vivo 
environment for testing. In the body, most cells grow in their own extracellular matrix (ECM). 
To replicate native ECM, a scaffold must serve as an artificial structure in vitro that permits cells 
to behave like they would in the body. For tissue applications, it would be best to use a material 
that has similar properties to the natural ECM of the targeted tissue so that the cells will be in a 
realistic environment (Chan and Leong, 2008). There are varying degrees of stiffness throughout 
the body, ranging from brain tissue to bone. Some cells need to have a stiffer surface to adhere to 
while others may not need as much support and anchorage as they grow (Chan and Leong, 
2008). All of these properties must be taken into consideration when creating a scaffold for tissue 
engineering applications. 
2.2.3 Hydrogels 
A hydrogel consists of hydrophilic polymer chains that are cross-linked together using either 
physical or chemical means. Either natural or synthetic polymers can be used for the creation of 
hydrogels. Hydrogels swell greatly in the presence of water, and may have a water content of 
more than 30% by weight (Drury and Mooney, 2003). Hydrogels are a promising material for 
tissue engineering scaffolds because they effectively simulate the properties of native human 
tissue. 
2.2.4 Hydrogel Precursors 
Collagen is a natural protein that is native to the human body. Within the human body it comes 
in five types, I-V, but there are at least 14 other types of collagen found in nature (Drury and 
Mooney, 2003). Hydrogels made out of collagen are relatively biocompatible, although some 
forms of collagen, such as those that are animal-derived, have been shown to be weakly 
immunogenic (Gorgieva and Kokol, 2011). Collagen hydrogels are also biodegradable, being 
naturally degraded by collagenase and serine proteases in the human body (Drury and Mooney, 
2003). The mechanical properties of collagen are difficult to fine-tune during the production 
process, and there may be variation between different batches of collagen due to sourcing 
(Tronci, 2010). 
Gelatin is a naturally derived protein that is produced by the denaturing collagen. Gelatin 
hydrogels are very biocompatible, showing none of the immunogenic responses of collagen due 
to very careful purification and sterilization during manufacturing. This manufacturing process 
also eliminates batch variation that is seen in collagen (Gorgieva and Kokol, 2011). Hydrogels 
made from gelatin have also been shown to biodegrade naturally through hydrolysis over the 
course of several weeks. In addition, gelatin hydrogels are also proangiogenic, supporting the 
growth of new vascular tissue from existing vascular tissue (Tronci, 2010).  
Poly (ethylene glycol), or PEG, is a synthetic polymer used in the creation of hydrogels. Because 
it is synthetic, it has mechanical properties superior to natural hydrogels, and these properties can 
be fine-tuned during the production process. It can also be altered to be biodegradable. However, 
there is a possibility of immune response due to PEG (Kasko, 2013).  
Acrylamide is another synthetic polymer used to make hydrogels. It has superior mechanical 
properties to natural hydrogels, because they can be specified during production. Many 
acrylamide hydrogels are cross-linked using UV light, making them unsuitable for cell 
encapsulation and 3D culture (Tse and Engler, 2011). 
2.2.5 Properties 
The physical properties of hydrogels including tensile strength, elasticity and compressibility, 
can be greatly affected by the characteristics of both the polymer and the cross-linker. The 
mechanical properties can also change over time due to swelling and degradation, both of which 
tend to weaken the gel (Drury and Mooney, 2003). Stiffness in particular has been shown to vary 
greatly with both the concentrations of polymer precursor (Tse and Engler, 2011) and of cross-
linking agent (Wang et al., 2012). 
The degradation rate of a hydrogel can also be designed during production. The degradation rate 
of gelatin-HPA-Tyr hydrogels has been linked to their stiffness, with an increasing stiffness 
corresponding to a slower degradation rate (Wang et al., 2012). The degradation rate of some 
synthetic gels, such as PEG, can also be controlled through the addition of degradable ester 
linkages (Kasko, 2013). 
Hydrogels swell greatly in the presence of water do to their hydrophilic properties. This swelling 
can be quantified using a degree of swelling, which can be calculated using the following 
equation: 
   
(     )
  
 
In this equation, Ws is the weight of the hydrogel after complete swelling and Wd is the weight of 
the hydrogel when it is completely dry (Andreaopoulos et al., 1998). 
The mesh size is the space between the polymer chains of a hydrogel. It can be calculated using 
the following equation: 
    (    
 )    
In this equation, ξ is the mesh size, αs is the linear deformation in distance between cross-links 
from a swollen to a non-swollen state, Cn is the characteristic ratio of the polymer, l is the bond 
length of the polymer backbone and n is the number of bonds between two cross-links 
(Andreaopoulos et al., 1998). 
Both the polymer and the cross-linking method affect the biocompatibility of a hydrogel. In 
order for a hydrogel to be biocompatible a polymer must be chosen that is neither cytotoxic to 
the cells, nor creates cytotoxic degradation products. If a chemical cross-linker is used, it must 
not be toxic to the cells or degrade into toxic products. If a physical cross-linking method is used 
it must not be harmful to the cells, such as those that involve high shear stresses or UV light.  
Finally, a hydrogel can be either 2D or 3D. In 2D hydrogels, cells are cultured only on the 
surface of the gel. In a 3D hydrogel, cells are cultured throughout the entire gel. Proper diffusion 
of nutrients and waste products is an important concern when working with 3D hydrogels. 
2.2.6 Cross-linking 
As aforementioned, a hydrogel is a cross-linked polymer network. There are a variety of cross-
linking mechanisms that can be used to form the networked structure of hydrogels. The method 
used to create cross-links must be selected with consideration of how it will affect the properties, 
such as gelation time, mechanical modulus, and biocompatibility, of the hydrogel. Generally, 
there are three main components involved in cross-link formation: monomers, initiators, and 
cross-linkers (Ottenbrite et al., 2010). Highlighted in this section are several cross-linking 
techniques and a description of how they each can be used to manipulate specific hydrogel 
characteristics. 
Cross-linking Methods 
Cross-linking methods can be categorized into physical and chemical processes. Physically 
formed hydrogels are held together by networks of physically connected junctions (Ottenbrite et 
al., 2010). These linkages can be made from molecular entanglements, crystalline regions, 
phase-separated microdomains, and secondary forces such as ionic bonds, Hydrogen bonds, and 
hydrophobic forces. Physical gels tend to be unstable and degrade at a fast, unpredictable rate. 
Chemically bonded hydrogels are more commonly used in biomedical applications because 
covalently bonded linkages allow the gel to swell while maintaining structural integrity. Several 
methods commonly used to form cell-encapsulating hydrogels for biomedical applications are 
described below. 
Radical Chain Polymerization 
This method of cross-linking is commonly used to form hydrogels with vinyl-bearing macromers 
(Ottenbrite et al., 2010; Nicodemus and Bryant, 2008). This process is typically used with the 
synthetic polymers poly(vinyl alcohol) (PVA) and poly(ethylene glycol) (PEG), or with the 
natural polymers hyaluronic acid (HA), chitosan, and dextran. Polymers can be modified to 
contain two or more vinyl groups, making them capable to undergo this cross-linking method. 
During radical chain polymerization, radicals are created when a cross-linking initiator is 
exposed to a stimulus, such as change in temperature or exposure to light. These radicals 
propagate through carbon-carbon double bonds to create covalently linked kinetic chains, 
forming a networked structure. Common ways to initiate the cross-linking reaction are to 
introduce redox or thermal initiators or to use UV light to induce photopolymerization. Redox-
initiating systems use a two-component initiator, for example a peroxide oxidizing agent and an 
amine reducing agent, that initiate polymerization when mixed.  Photoinitiation with UV light 
specifically is advantageous because it provides rapid cross-linking, but exposing encapsulated 
cells to UV light can have an adverse effect on cell viability. Another drawback is that the heat 
produced during cross-linking can cause cellular necrosis. In general, some initiators and 
generated radicals can be toxic to cells. Consideration of the chemistry of the reaction, 
concentration of the initiator, and length of exposure to UV light can help to reduce these 
cytotoxic effects. Some methods of cross-linking that use visible light photoinitiators, such as 
eosin-Y, triethanolamine, and camphorquinone, have been used to avoid the adverse effects of 
UV light exposure. 
Cross-linking of Functional Groups 
This method of cross-linking occurs through reactions between the functional groups of water-
soluble monomers. Some categories of these reactions include: Schiff-base formation, and 
Michael-type additions (Ottenbrite et al., 2010; Nicodemus and Bryant, 2008). 
Schiff-base formation of a hydrogel involves linking an aldehyde and an amino group (Ottenbrite 
et al., 2010). Glutaraldehyde is commonly used as a cross-linker in hydrogels, but has been 
found to be highly toxic to cells. Alternatively, reactive aldehyde groups can be created through 
the oxidation of a polysaccharide such as dextran, hyaluronic acid, or alginate. Hydrogels formed 
using Schiff-bases can be subject to degrade through the hydrolysis of imine bonds at low pH, 
but the addition of borax, a basic component, can produce stable hydrogels with fast gelation 
times. 
Michael-type addition reactions are most common in making injectable hydrogels (Ottenbrite et 
al., 2010). The reactions occur when two polymers that contain nucleophilic groups, such as an 
amine or thiol, and electrophilic groups, such as a vinyl, acrylate, or maleimide, are mixed. 
Numerous polymers can be conjugated with these groups, but most commonly hyaluronic acid, 
dextran, PVA, and PEG are used. Hydrogels synthesized from Michael-type addition have a 
moderate gelation time that ranges from 0.5 to 60 minutes. Properties of these hydrogels can be 
modified by adjusting the reactivity of the functional groups and cross-linking density. Another 
characteristic of hydrogels formed through this reaction is that they usually provide favorable 
environments for cell proliferation as long as there are no excess thiol groups, which can cause 
cell death. 
Enzymatic Reactions 
Hydrogels can be cross-linked from polymers and polypeptides through enzymatic reactions 
(Ottenbrite et al., 2010). Commonly used to initiate these reactions is transglutaminase, a 
calcium-dependent enzyme that forms amide linkages between carboxamide and primary amines 
on polymers or polypeptides. Another initiator, horseradish peroxidase, causes linking of phenols 
or aniline derivatives when exposed to hydrogen peroxide. This method has been used to 
formulate hydrogels from phenol conjugated poly(aspartic acid), as well as with hyaluronic acid, 
dextran, cellulose, alginate, and gelatin (Wang et al., 2012). Hydrogel properties can be modified 
by a variation in the horseradish peroxidase/hydrogen peroxide ratio. The gelation time for this 
method of cross-linking is under one minute, and can be adjusted by increasing or decreasing the 
enzyme concentration. 
Thermo-Gelation 
Thermo-gelation occurs when a change in temperature stimulates a hydrophobic interaction to 
occur (Ottenbrite et al., 2010). Biodegradable thermo-sensitive hydrogels can be made from 
block or graft copolymers that contain hydrophilic PEO and hydrophobic PLA, however they are 
slightly cytotoxic. Naturally occurring polymers, such as gelatin and agarose, can also form 
thermo-sensitive biodegradable hydrogels.  
Combining Physical and Chemical Cross-linking 
Physical and chemical cross-linking processes can be combined to create hydrogels with 
improved mechanical properties (Ottenbrite et al., 2010). Physical cross-linking reactions create 
reversible hydrogels with low mechanical properties. Chemical cross-linking reactions create 
irreversible hydrogels with high mechanical properties, but in many cases the reagents can 
adversely affect the biocompatibility of the gel. By applying two cross-linking methods, one 
physical and one chemical, the hydrogel becomes double cross-linked and can have improved 
mechanical properties, biocompatibility, and gelation times.  
Cross-linking Considerations 
The properties of a hydrogel, such as gelation time, mechanical modulus, swelling, degradation, 
and biocompatibility, are largely determined by the method of cross-linking that is used during 
formulation (Ottenbrite et al., 2010; Nicodemus and Bryant, 2008). Generally, an increase in 
cross-linking density increases mechanical properties of a hydrogel while decreasing swelling 
and mesh sizes. When forming a 3D hydrogel for cell encapsulation, the effect of the cross-
linking method on cell viability must be considered. This is because cells are being mixed with 
gel precursor prior to being cross-linked, and are therefore exposed to the reactions occurring 
during the cross-linking process. Some cross-linking mechanisms, like glutaraldehyde initiators 
and exposure to UV light, can have a high level of toxicity to cells, and therefore cannot be used 
for cell encapsulation methods. 
2.3 Cell Response to Stiffness In vivo 
Cells are anchorage dependent, meaning they must attach to a surface in order to proliferate. 
Cells also exhibit a characteristic called durotaxis, meaning they show a preference for a specific 
level of stiffness. Depending on the type of cell, this preference can range from a very soft 
surface, to a very rigid one. The various degrees of stiffness in vivo and their effect on cells is 
explored in this section. 
2.3.1 Stiffness of Tissues In vivo 
Within the body there is a wide range of stiffness that occurs. Stiffness can be defined as the 
ability of a material to resist deformation (Mason et al., 2012). Some tissues have a very low 
stiffness, such as brain tissue (260-490 Pa), a moderate stiffness, such as muscle (10kPa) and 
some tissues have a very high level of stiffness, such as pre-mineralized bone (30kPa) (Breuls et 
al., 2008; Sunyer et al., 2012). Tissue stiffness can be subject to change throughout certain 
physiological processes such as embryonic development, wound healing, and tumorigenesis 
(Mason et al., 2012).  
Natural stiffness gradients can be caused by a pathological condition, such as myocardial 
infarction, which can cause a gradient of 8.7± 1.5 kPa/mm, or due to normal variation in tissue, 
such as mycocardium, which can have a gradient of 0.6±0.9 kPa/mm (Tse, 2011). At interfaces 
in the body, such as when rigid bone is connected to soft ligament, natural stiffness gradients 
occur. This transition consists of a shift from ligament to fibro-cartilage to bone. Natural 
gradients occur in teeth, where the composition and mineral density varies, and in bone 
structures, where bone composition and porosity ranges from compact (5-30% porosity) and 
spongy (30-90% porosity). Another cause of localized tissue stiffness variation is the formation 
of malignant tumors, which are stiffer than surrounding healthy tissue (Sunyer et al., 2012).  
2.3.2 Effects of Stiffness on Cell Processes 
Cells are very responsive to stiffness, as it has an effect on multiple cell processes such as 
proliferation, migration, morphology, and differentiation. As cells interact with their ECM 
environment, they probe and sense the stiffness of their surroundings (Mason et al., 2012). There 
have been several cell behavior studies conducted to observe these effects.  
Studies involving chondrocytes have shown that when cultured in a stiff hydrogel with a 
modulus of approximately 500 kPa, chondrocytes are retained in a proliferative state (Drury and 
Mooney, 2003). However, when these same cells are cultured in a less stiff hydrogel they were 
found to differentiate. A different study that plated heart tissue explants on stiff and soft matrices 
found that at high stiffness cells migrated out of the explant to cover the culture plate, while at 
low stiffness they did not (Mason et al., 2012). Some cells, such as rat kidney epithelial and 
fibroblasts, migrate at faster rates on softer matrices, while vascular smooth muscles migrate 
faster on intermediately stiff matrices (Breuls et al., 2008). Other studies show that matrix 
stiffness influences cell morphology, as it regulates polarization and alignment of stress fibers 
within cells. Stiffer substrates tend to cause spreading of cells, while soft substrates cause a 
more-rounded morphology.  
Cellular differentiation is influenced by genetic, chemical, and mechanical factors (Mason et al., 
2012). During embryonic development, the cytoskeletal contraction of cells can increase the 
level of stiffness in surrounding tissue by as much as 50-fold over the course of eight hours. 
Many studies have been conducted to observe the effects of stiffness on stem cell differentiation, 
and have determined that stiffness plays an integral role in regulating cell differentiation. When 
cultured on substrates that have a stiffness corresponding to native tissue, stem cells undergo 
lineage-specific differentiation (Tse and Engler, 2011). For example, mesenchymal stem cells 
can be differentiated into neurons when cultured on soft matrices, or into osteoblasts when plated 
on a stiff matrix of similar chemical composition (Engler et al., 2006).   
2.4 Stiffness Gradient 
Many research groups have been able to model hydrogels with a constant stiffness throughout a 
hydrogel. The ability to create hydrogels with varying stiffness is crucial to properly model an in 
vivo environment. As stated in the previous section, cells display durotaxis, which cannot be 
properly modeled on a constant stiffness. To create a hydrogel with varying stiffness there are 
two major components to consider.  The first is the molecular level.  As discussed in previous 
sections the cross-linking agent chosen to form a hydrogel will affect its mechanical properties. 
Secondly, the physical method for gradient generation must be determined.  Microfluidics, 
controlled mixing, and injections of reagents are currently used processes.  
2.4.1 Hydrogel Creation  
There are two main components of a hydrogel: the gel precursor and the cross-linker.  Either of 
these materials can be altered to vary the resulting mechanical properties. A gradient can be 
formed by varying the molecular weights of the material used. A higher molecular weight will 
result in a higher stiffness upon hydrogel formation. A gradient can also be formed by altering 
the cross-linking agent’s intensity. For chemical cross-linking methods, such as heat and 
photocross-linking, extending the exposure to the cross-linker will result in a greater density of 
cross-linking and therefore a stiffer hydrogel. An increase in intensity can also have this effect 
(Nemir et al., 2010). There are however limits to these cross-linking methods. Certain hydrogel 
materials may become denatured or damaged if exposed to dramatically high temperatures or 
intense light. In addition, when preparing 3D hydrogels, only biocompatible materials and 
methods can be used, greatly narrowing the available options.  
2.4.2 Gradient Creation 
Different methods have been developed to physically form a stiffness gradient. The combination 
of materials must be a precise process to ensure that gradient is smooth and uniform. Some 
methods are compatible will either the change in molecular weight or the change in cross-linker 
intensity as primary gradient generation techniques, while others are applicable to just one.  
Several current methods for forming gradients are summarized below.  
Source Sink Gradient Generation 
The Source Sink method differs from most that will be discussed as it does not involve syringes 
or pumps to control flow. This method depends on the natural diffusivity of materials. In order to 
work with this method, the materials used to make the hydrogel must have significantly different 
diffusivity coefficients. A mold with two inlets on 
opposite ends are connected by a channel (Figure 
2.1). Each inlet is filled with a different material. 
The materials then fill into the channel and, based 
on their respective properties, a sink and a source 
Figure 2.1: Source Sink Diffusion 
(Sant et al., 2010) 
will develop. The natural mixing that happens as a result of this development creates as gradient. 
This process however should not be used if time is a concern for gradient creation as this natural 
gradient process can take extensive amounts of time (Abhyankar et al., 2006).  
Gradient Generator 
A gradient generator can also be used to 
produce a stiffness gradient. This generator 
is composed of microchannel networks that 
attach to a mechanism to force the material 
through the channels to form a gradient. 
There are many different patterns that can 
be formed using this method depending on 
the structure of the generator’s network. 
Gradient generators are capable of mixing different materials, such as chemical cross-linking 
agents of varying intensity or varying molecular weight. This results in a different concentration 
or weight to be expelled from each channel. For this system to be effective, the flow of the 
materials into the generator must be steady and constant. A main advantage of this process is that 
it can occur very quickly. In some cases injection can occur in under a minute depending on the 
desired size of the hydrogel. One consideration is that this tool creates a gradient perpendicular 
to the direction of the flow. A visual representation of this variation can be seen in Figure 2.2 
(Sant et al., 2010). 
Dynamic Mixing 
Another generation method that involves the 
injection of materials into a mold is dynamic 
mixing. This is a simple method that uses two 
syringes and a mixer.  The syringes can be filled 
with various solutions and then injected at 
different rates. The solutions are then mixed when 
they reach the mixing attachment. The gradient 
that results can be varied depending on the input 
Figure 2.2: Gradient Generator (Sant et al., 2010) 
Figure 2.3: Dynamic Mixing (Sant et al., 
2010) 
from the two syringes. Through constant variation in the injection rates a gradient can be formed. 
This method is can create a gradient through a fairly short injection time. 
Convective Spreading 
Convective Spreading involves the injection of two material 
solutions into a mold. The mold has two inlets on either side in 
which the solutions can be injected. The lower concentration or 
weight solution is injected into the first inlet while a filled 
second syringe is connected into the remaining inlet. After the 
mold has been filled with the first solution, the initial syringe is 
drawn back. This results in the solution of the second syringe 
being drawn into the mold. The first syringe should then again 
be expelled to inject the contained solution back into the mold.  
Repeating this process several times will eventually result in gradient formation. The more time 
this process occurs the longer the resulting gradient will be. 
Ultraviolet Exposure 
Certain material used to make hydrogels, such as collagen, can be cross-linked through exposure 
to Ultraviolet (UV) light. Creating a gradient with this method is a simple concept. The cross-
linking density is directly related to the amount of time of exposure. Processes to create a 
controlled gradient have been developed by controlling the exposure to UV light. One technique 
is the use of a greyscale mask. This mask has a greyscale gradient, which is placed on top of the 
hydrogel so that a gradient forms as the intensity of UV light varies through the mask. This is an 
example of a variation in intensity that results in different stiffness. The gradient can also be 
created through longer or shorter exposure periods. For this method, the entire hydrogel is 
initially exposed to UV light. Then a mask is slid at a controlled rate over the hydrogel to block 
the light (Sant et al., 2010). 
2.4.3 Stiffness Measurement Techniques 
There are several ways to measure stiffness gradients. Two main methods are using Atomic 
Force Microscopy and Rheology. 
Figure 2.4: Convective 
Spreading (Sant et al., 2010) 
Atomic Force Microscopy 
In Atomic Force Microscopy, a cantilever spring that has a tip with a radius of 10 to 50 
nanometers is pulled across the surface of the material (Helm, 2012). As the tip is pulled across, 
a laser reflects off of the cantilever spring and into a photodetector. Depending on where the 
laser’s reflection hits the photodetector, the microscope can record the displacement of the tip, 
therefore allowing for the calculation of force and substrate stiffness (Helm, 2012).  
 
Figure 2.5: Measurement through Atomic Force Microscopy (Helm, 2012) 
There are various modes of use for Atomic Force Microscopes. In contact mode, the tip is pulled 
across the surface as it is making direct contact with the material. This mode is generally used for 
stiffer materials since the tip does not leave the surface of the material. Another method 
commonly used is noncontact mode. In noncontact mode, the tip on the cantilever spring 
oscillates directly above the surface of the sample material without ever touching it. By sensing 
the van der Waals forces, the tip is able to oscillate right above the surface, allowing for 
measurements to be recorded that calculate the forces and stiffness (Nanoscience Intruments, 
2013). A final commonly used mode is intermittent contact mode. In this mode, the tip of the 
Atomic Force Microscope again oscillates directly above the surface of the material. As its name 
suggests, the tip touches down on the surface occasionally to collect more data on the stiffness 
and strength of the sample material (Nanoscience Instruments, 2013). Both noncontact and 
intermittent contact modes are commonly used when measuring the characteristics of hydrogels 
and other soft materials because the tip does not damage the surface of the materials. 
Acoustic Rheology 
In Acoustic Rheology, a piezoelectric crystal launches contraction and extensional waves 
through the material that is being tested. These waves cause extensional stresses to oscillate 
through the material. Once these waves travel through the material, the amplitude, frequency, 
sound waves, and other factors can be recorded. In this method, the rheometer does not ever 
make contact with the material, ensuring that no damage occurs (McDonagh, 2010). 
  
Chapter 3: Project Strategy 
3.1 Initial Client Statement 
The team was given the following initial Client Statement in order to define project objectives, 
constraints, and functions. 
“Substrate stiffness and external mechanical stimuli can affect cell behavior such as cell 
locomotion, morphology, adhesion, and cytoskeletal protein expression. Traditionally, 
studies on the effect of substrate stiffness on cellular response have been done on 
materials of discrete stiffness separately. Inside the body, tissue stiffness is not uniform 
and therefore, adjacent cells may experience different stiffness leading to different 
responses. This phenomenon needs to be explored in vitro in order to better understand 
cell behavior in vivo. 
 
The needs of this project are 
1. Develop a method to manufacture 3D gel (scaffold) with a continuous stiffness 
gradient.  
2. The gel should be transparent so that cells can be imaged using a regular microscope. 
3. Scaffold should be of uniform thickness of about 100-500 microns, preferably in the 
100-200 micron range. 
4. Choose from natural ECMs (e.g. collagen), commercially available hydrogels or 
synthetic polymers to prepare the gel (preferably biodegradable). 
5. Ability to embed (mix) cells in the scaffold before cross-linking. 
6. Choose a suitable cross linker that does not affect cell viability. 
7. A method to generate a gradient of the cross-linker across the scaffold to complete 
cross-linking within 2 to 20 minutes, preferably less than 10 minutes. 
8. Standardize a measurement technique to consistently measure and determine the 
stiffness gradient across the gel(s). 
9. Develop a method to visually determine the gradient (under a microscope) across the 
gel. 
10. Determine cell behavior in the gradient gel.” 
3.2 Design Objectives 
From the initial Client Statement, the team created a compilation of items that would be 
important to meet all goals. From this compilation, a final list of objectives was created in 
accordance with the needs of the client. These objectives are shown in an objectives tree (Figure 
3.1) and are explained in further detail below.  
 Figure 3.1: Objective Tree 
Biocompatible: The hydrogel must be biocompatible in order for cells to survive inside of it. 
The hydrogel should be a safe environment for the cells to mature, proliferate, and move about. 
If the environment is toxic to the cells, they will not survive within it and the team will not be 
able to study cell behavior. 
Biodegradable: The hydrogel should be biodegradable so that the cells can move throughout it. 
Also, in order for the cells to proliferate and grow in place of the hydrogel scaffold, it will be 
necessary for degradation to occur. If the hydrogel is not biodegradable, the cells will not be able 
to easily move throughout the gel and they won’t be able to proliferate to form their own 
scaffold. 
Capable of rapid gelation: The scaffold will need to be capable of rapid gelation so that cells 
can be uniformly distributed throughout the hydrogel without sedimenting.  
Continuous Gradient: The hydrogel should have a continuous stiffness gradient in order to 
study cell behavior. By incorporating a wide range of stiffness, the hydrogel will more accurately 
represent the varying degrees of stiffness found throughout the body. 
Measurable: The hydrogel will need to be measurable in order to determine the stiffness at any 
given location. If the hydrogel is not measurable, the team will not be able to determine the cells 
behavior in different stiffness regions. 
Reproducible: The hydrogel scaffold should be reproducible. For the team to be able to test a 
variety of cell types and situations, it will be necessary to create multiple hydrogel scaffolds that 
all have the same exact properties. If the hydrogels do not have the same properties, then it will 
not be possible to accurately determine cell behavior. 
Three-dimensional (3D): The hydrogel scaffold should be three-dimensional so that cell 
behavior can be studied. Since cells in vivo are able to grow in all planes rather than just a flat 
surface, it will be important to make the hydrogel 3D. By having a 3D hydrogel, cells will be 
able to grow in an environment that better simulates an in vivo setting. 
Uniform Thickness: The hydrogel should have a uniform thickness so that cells have an equal 
opportunity to grow anywhere in the structure. If the hydrogel is not uniform in thickness, it will 
make it more difficult to determine whether the cells are responding the gradient or to the 
amount of space available. 
From these objectives, the team created a joint pairwise comparison chart. In a pairwise 
comparison chart, each objective is listed and ranked against the other objectives. The objective 
that is determined to be more important receives a 1 while the other objective receives a 0. If the 
objectives are determined to be equally important, each receives a 0.5. After the entire chart is 
filled in, the objective totals are determined. 
Table 3.1: Pairwise Comparison Chart 
 
Continuous 
Gradient 3D Biodegradable Biocompatible Reproducible 
Uniform 
thickness Measurable 
Capable 
of rapid 
gelation Score 
Continuous 
Gradient 
 0.5 1 0 1 1 1 1 5.5 
3D 0.5  1 0 1 1 1 1 5.5 
Biodegradable 0 0  0 1 1 1 0 3 
Biocompatible 1 1 1  1 1 1 1 7 
Reproducible 0 0 0 0  1 0 0 1 
Uniform 
thickness 
0 0 0 0 0  0 0 0 
Measurable 0 0 0 0 1 1  0 2 
Capable of 
rapid gelation 
0 0 1 0 1 1 1  4 
 The results obtained from the team’s pairwise comparison chart were presented to the client. 
After discussion, the team and clients agreed to rank the objectives in the following order: 
1. Biocompatible 
2. Continuous Gradient and 3D (tie) 
4.  Capable of rapid gelation 
5. Biodegradable 
6. Measurable 
7. Reproducible 
8. Uniform Thickness 
3.3 Design Constraints 
After reviewing the needs identified in the initial client statement and developing design 
objectives, the team identified the following constraints for the project design: 
 The hydrogel must be between 100-500 microns thick 
 Cross-linking must complete between 5-20 minutes 
 The stiffness gradient must range within 1-100 kPa 
 The hydrogel must be at least 90% transparent 
The hydrogel design must be able to sustain cell culture and illustrate the cellular response to a 
stiffness gradient in vitro. This means that sufficient nutrient and cell waste diffusion must be 
able to occur to promote cell proliferation. The distance between a cell and capillary in vivo 
rarely exceeds 100 microns (Sherwood, 2010), so the thickness of the hydrogel must replicate 
this diffusion distance as accurately as possible. One of the most important features of the 
hydrogel design is its stiffness gradient. The hydrogel design is intended for research where a 
variety of cell types are cultured, and so it must encompass the range of stiffness that can be 
experienced in biological tissues. In order for cell behavior to be studied during culture, the 
hydrogel needs to be transparent enough for cells to be viewed under a microscope. These 
constraints aim to promote a design that can be repeatedly fabricated with consistent properties 
every time. 
3.4 Revised Client Statement 
After meeting with the team’s project advisors to clarify the initial client statement and to discuss 
the project objectives and constraints, the team revised the initial client statement as follows: 
“As research in the Tissue Engineering field is evolving, there is a need for a scaffold that 
can simulate an in vivo environment as accurately as possible. To achieve this, the scaffold 
should be a hydrogel that is three-dimensional, biocompatible, and biodegradable. It should 
have a continuous stiffness gradient ranging from 1 kPa to 100 kPa, a gelation time of under 
20 minutes, and the ability to embed cells within the gel prior to cross-linking without 
affecting cell viability.” 
3.5 Project Approach 
In order to successfully create a 3D cell encapsulating hydrogel with a continuous stiffness 
gradient, the team developed a strategy for approaching the project. First is to develop a hydrogel 
formula that will serve as the basis for every scaffold. Once the gel is created, it will be tested to 
verify that the stiffness gradient within it is continuous. Finally, cell behavior within the hydrogel 
will be studied. 
To create the hydrogel, the team must consider possible gel precursors, as well as a method of 
cross-linking and gradient creation. Since cells will be embedded into the hydrogel, the team 
must consider cell viability when choosing the cross-linking and gradient formation method.  
To actually create the stiffness gradient the team will conduct research on existing gradient 
generation methods, evaluate which method would be optimal for the purpose of this project, and 
then make appropriate modifications to enable cell encapsulation.  
Once the hydrogel is created, the team will need to measure the mechanical properties of the 
hydrogel. Mainly, the levels of stiffness must be evaluated throughout the hydrogel to verify that 
a continuous stiffness gradient has been formed. To do this, Atomic Force Microscopy (AFM) 
will be used. The team will continue to test hydrogels and refine the design until it is determined 
that a hydrogel with a continuous stiffness gradient has been created. 
Upon finalizing the hydrogel formula and determining its stiffness gradient to be continuous, the 
team will begin a cell culture study over the course of three to four weeks. Cells will be prepared 
using immunocytochemistry prior to embedment to allow for fluorescence microscopy to be 
conducted, distinguishing live from dead cells. Imaging will provide qualitative results to show 
the effect of stiffness on cell behavior over the period of time it was cultured, as well as validate 
the capacity of the hydrogel to promote cell growth. 
3.5.1 Project Considerations 
For project planning purposes, the project approach is broken down into specific technical, 
management, and financial considerations in the following section. The design challenges, 
design alternatives, timeline, work breakdown, and projected costs will be specifically evaluated. 
Technical Considerations 
There are several challenges the design must overcome in order to be successful. The most 
important of these is the encapsulation of cells uniformly throughout the hydrogel without 
affecting their viability. To accomplish this the design must employ a method of cross-linking 
and gradient generation that is neither toxic to the cells nor induces a large amount of shear stress 
on them. Cross-linking of the hydrogel must also occur in less than twenty minutes, so that the 
cells do not fall out of suspension before gelation is complete. 
Once the hydrogel is created, the cells must be imaged in order to determine their viability, 
mobility, and differentiation. A variety of stains and assays must be employed in order to 
distinguish between live and dead cells and between different cell types. The cells must also be 
imaged on a regular basis over a period of four weeks in order to observe their movement 
through the gel and to ensure long-term viability. It is also important that cells can be imaged in 
the center of the hydrogel, not just at the surface. It may also be necessary to perform 
histological sections to view the center of the culture, even though this would ultimately destroy 
the hydrogel.   
Another design challenge is the small size of the hydrogel. The hydrogel must be between 100 
and 500 microns thick. In order to work at this scale, the design must incorporate microfluidic 
methods that will allow for precise control of fluids at a small scale. 
Design Evaluation Matrices 
In order to quantitatively compare the design alternatives and finalize the primary design 
concept, a series of design evaluation matrices were generated. The design was broken into three 
components: hydrogel precursor, cross-linking method, and gradient generation method. Several 
options for each of these design components were measured against the design constraints and 
objectives. Each objective was assigned a weighted percentage based on its relative importance 
determined in the pair-wise comparison chart. 
The first design component to be analyzed was the hydrogel precursor. Collagen, gelatin, PEG 
and acrylamide were compared using the weighted objectives. Table 3.2 shows the design 
evaluation matrix for the hydrogel precursor. 
Table 3.2: Design Evaluation Matrix for Hydrogel Precursor 
Design Constraints 
 
Collagen Gelatin PEG Acrylamide 
Between 100-500 Microns 
Thick  
Y Y Y Y 
Cross-linking between 5-20 
minutes  
Y Y Y Y 
Stiffness gradient from 1-
100 kPa  
Y Y Y Y 
At least 90% transparent 
 
Y Y Y Y 
          
Design Objectives 
Weight 
(%) Score 
W. 
Score Score 
W. 
Score Score 
W. 
Score Score 
W. 
Score 
Biocompatible 25 0.7 17.5 0.9 22.5 0.6 15 0.4 10 
Continuous Gradient 20 1 20 1 20 1 20 1 20 
3D 20 1 20 1 20 1 20 1 20 
Capable of Rapid Gelation 15 0.9 13.5 1 15 0.8 12 0.8 12 
Biodegradable 10 1 10 1 10 0.8 8 0.4 4 
Measurable 5 1 5 1 5 1 5 1 5 
Reproducible 3 0.6 1.8 0.8 2.4 0.9 2.7 0.9 2.7 
Uniform thickness 2 1 2 1 2 1 2 1 2 
TOTAL 
  
89.8 
 
96.9 
 
84.7 
 
75.7 
 
Using the design evaluation matrix, it was decided that gelatin is the most suitable hydrogel 
precursor for the needs of the project with a score of 96.9. Gelatin was chosen oven the other 
options due to its biocompatibility, biodegradability and its capability of being gelled very 
rapidly. 
Once the hydrogel precursor was chosen, a comparison was done for possible cross-linking 
reagents. Genipin, carbodiimide, and horseradish peroxidase (HRP) coupled with hydrogen 
peroxide (H2O2) were compared against the weighted objectives. Table 3.3, below, shows the 
design evaluation matrix for the cross-linking reagents.  
Table 3.3: Design Evaluation Matrix for Cross-linking Reagent 
Design Constraints 
 
Genipin Carbodiimide 
HRP and 
H2O2 
Between 100-500 Microns 
Thick  
Y Y Y 
Cross-linking between 5-20 
minutes  
Y Y Y 
Stiffness gradient from 1-100 
kPa  
Y Y Y 
At least 90% transparent 
 
Y Y Y 
        
Design Objectives 
Weight 
(%) Score 
W. 
Score Score 
W. 
Score Score 
W. 
Score 
Biocompatible 25 0.9 22.5 0.8 20 0.9 22.5 
Continuous Gradient 20 0.8 16 0.8 16 0.9 18 
3D 20 1 20 1 20 1 20 
Capable of Rapid Gelation 15 0.5 7.5 0.8 12 1 15 
Biodegradable 10 1 10 1 10 1 10 
Measurable 5 1 5 1 5 1 5 
Reproducible 3 0.8 2.4 0.8 2.4 0.8 2.4 
Uniform thickness 2 1 2 1 2 1 2 
TOTAL 
  
85.4 
 
87.4 
 
94.9 
 
It was determined that HRP combined with hydrogen peroxide (H2O2) is the most viable option 
for the design. This cross-linking method was chosen due to its biocompatibility, rapid gelation 
rate, and capability of forming a stiffness gradient that can be controlled by H2O2 concentration.  
Finally, a preliminary design evaluation matrix was created for the method of gradient 
generation. Four methods were compared against the constraints and objectives: dynamic 
mixing, convective spreading, diffusion source sink and a gradient generator. Table 3.4 shows 
the design evaluation matrix for the gradient generation method 
 
 
The diffusion source sink method was ruled out due to the long time needed to complete the 
process. Of the remaining three, dynamic mixing was chosen as the most viable option for 
gradient generation due to its biocompatibility, capability of producing a continuous stiffness 
gradient and rapid gelation time. The gradient generator is a second option due to its capability 
of producing a continuous stiffness gradient that is reproducible. 
Management 
Taking into account all design alternatives, the team created a work breakdown structure. The 
break down shown in Figure 3.2 incorporates the main components of all possible designs. The 
first factor that must be determined is which hydrogel formula to use, and, more importantly 
Table 3.4: Preliminary Design Evaluation Matrix for Gradient Generation Method 
Design 
Constraints  
Dynamic 
Mixing 
Convective 
Spreading 
Gradient 
Generator 
Diffusion 
Source Sink 
Between 100-
500 Microns 
Thick 
 
Y Y Y Y 
Cross-linking 
between 5-20 
minutes 
 
Y Y Y N 
Stiffness 
gradient from 
1-100 kPa 
 
Y Y Y Y 
At least 90% 
transparent  
Y Y Y Y 
          
Design 
Objectives 
Weight 
(%) Score 
W. 
Score Score 
W. 
Score Score 
W. 
Score Score 
W. 
Score 
Biocompatible 25 0.9 22.5 0.9 22.5 0.8 20 N/A N/A 
Continuous 
Gradient 
20 0.9 18 0.7 14 1 20 N/A N/A 
3D 20 1 20 1 20 1 20 N/A N/A 
Capable of 
Rapid 
Gelation 
15 1 15 0.8 12 0.9 13.5 N/A N/A 
Biodegradable 10 1 10 1 10 1 10 N/A N/A 
Measurable 5 1 5 1 5 1 5 N/A N/A 
Reproducible 3 0.8 2.4 0.5 1.5 1 3 N/A N/A 
Uniform 
thickness 
2 1 2 1 2 1 2 N/A N/A 
TOTAL 100 
 
94.9 
 
87 
 
93.5 N/A N/A 
which cross-linking method will be compatible. Second, the gradient generation method must be 
determined. Evaluation of the mechanical properties of the hydrogels must also be performed.  
Finally the hydrogel will have to be studied for biocompatibility. This will be conducted by 
evaluating the proliferation of cells encapsulated within the entire hydrogel. 
 
 
 
 
 
 
 
 
 
 
 
 
 
A Gantt chart (Appendix A) was created to establish the team’s deadlines for project milestones.  
The general goals to be complete for the end of each term are as follows.   
 
 
 
A Term: Complete writing chapters 1-3 of report 
  Familiarize team with lab space and creation of hydrogels 
  Develop or select hydrogel formula and synthesis method 
  Finalize primary design and alternatives 
B Term: Create hydrogel gradient machine 
  Create hydrogels using team-developed methodology 
  Analyze produced hydrogels 
  Make design alterations as necessary 
  Record all team progress 
C Term: Continue recording progress and write results 
  Culture cells in hydrogels 
  Perform assays and cell counts 
  Track cell response to stiffness 
Figure 3.2: Work Breakdown Structure 
   
D Term: Finish all experiments 
  Finalize results 
  Write discussion 
  Prepare final presentation 
Chapter 4: Design Alternatives 
Presented in this chapter are the preliminary developments of the design. The needs, functions, and 
specifications are summarized, the design alternatives are presented and evaluated, the final design is 
chosen, and feasibility studies, calculations, and preliminary experiments and results are explored. 
4.1 Needs Analysis 
After discussions as a team and with the project advisors, and after receiving feedback during 
presentations on the preliminary development of the team’s project, the needs of the project were 
evaluated and solidified. The top objectives were identified and used to distinguish the functional 
needs from the needs that are desired but not crucial to the design. 
Originally the needs identified by the clients in the Client Statement included: 
 Develop a method to manufacture 3D gel (scaffold) with a continuous stiffness gradient. 
 The gel should be transparent so that cells can be imaged using a regular microscope. 
 Scaffold should be of uniform thickness of about 100-500 microns, preferably in the 100-
200 micron range 
 Choose from natural ECMs (e.g. collagen), commercially available hydrogels or 
synthetic polymers to prepare the gel (preferably biodegradable). 
 Ability to embed (mix) cells in the scaffold before cross-linking. 
 Choose a suitable cross linker that does not affect cell viability. 
 A method to generate a gradient of the cross-linker across the scaffold to complete cross-
linking within 2 to 20 minutes, preferably less than 10 minutes. 
 Standardize a measurement technique to consistently measure and determine the stiffness 
gradient across the gel(s). 
 Develop a method to visually determine the gradient (under a microscope) across the gel. 
 Determine cell behavior in the gradient gel. 
The top three ranked objectives determined from the teams pairwise comparison chart are that 
the design must be biocompatible, contain a continuous gradient, and be three-dimensional. 
Based off of these objectives, the team decided that the necessary characteristics of the design 
include: biocompatibility with cells, methods to develop a 3D continuous stiffness gradient, and 
the ability to encapsulate cells through rapid gelation. Additionally, the team will need to create 
standard methods for measuring and determining the stiffness gradient across the gel in order to 
validate the success of the design. 
The team also evaluated the other needs based on the results of the pairwise comparison chart. 
The following characteristics have been classified as wants: transparency of the gel, the ability of 
the scaffold to biodegrade, uniform scaffold thickness, visualization of the gradient under a 
microscope, and determination of cell behavior in the final design. 
The rationale for classifying these characteristics is as follows. The gel must be transparent 
enough to image the cells under a microscope.. The client specified the biodegradability of the 
scaffold as a preference, but not a necessity. Ideally, the team would prefer to create a 
biodegradable scaffold that would allow cells to replace the hydrogel with their own matrix, 
however this is not a functional need of the project. Uniform scaffold thickness was the lowest 
ranked objective, as it is a design parameter that is not crucial to the design functionality and can 
be refined in the future. The team determined that validation of the gradient visually under a 
microscope is not a necessity, as the gradient can be validated in other ways by measuring the 
stiffness across the gel. However the team would ideally prefer to visualize the gradient. Lastly, 
the clients and the team would both like to study cell behavior within the final gradient gel, 
however this does not directly impact the functionality of the design and is therefore classified as 
a want. 
The team developed a list of physical limitations that impact the scaffold design. The scaffold 
thickness must fall within the 100-200 micron range in order for cells to thrive. At a thickness 
greater than 200 microns, a necrotic core tends to develop. The design must have a gelation less 
than 20 minutes, otherwise the cells will sink to the bottom of the gel and the system will no 
longer be 3D. The cross-linking method and polymers used in this design must be biocompatible 
so that cells can be encapsulated and cultured within the hydrogel. 
4.2 Design Functions and Specifications 
To more fully develop the design criteria, this section describes the specific functions the design 
must be capable of. The necessary specifications are also introduced. 
4.2.1 Functions 
For this scaffold to be an effective cell culture tool there are several necessary functions. Cell 
culture is a very dynamic process that requires the proper environment for cell survival. In 
addition, this scaffold will have several more functions than tradition cell culture methods. 
Cell Response 
The major purpose of this scaffold is to allow for the study of the cell behavior when 
encapsulated in a range of stiffness. This differs greatly from other traditional cell culture 
methods and will provide an environment more similar to that found in vivo.  This will allow for 
the study of cell morphology and proliferation as the cells react to the gradient and migrate 
throughout the gel towards their preferred environment. 
Support Cells and Proliferation 
The scaffold must be able to support the proliferation of cells within. This means that all stages 
of its synthesis and the materials that it is composed of must be non-toxic and biocompatible. For 
the cells to continue to grow and proliferate, nutrients and proper culture environment must be 
maintained. This means that the gel must be a permeable material. The nutrients must be able to 
diffuse into the hydrogel to reach the cells and metabolic waste must be able to diffuse out of the 
system. 
Degradation 
It is important that the hydrogel is a degradable material. This is because this scaffold is intended 
to allow for the study of cell morphology as well as monitoring cell proliferation. As the cells 
continue to proliferate it is possible for them to develop their own structure, independent of the 
scaffold. For this to happen, however, the scaffold must degrade over time. This degradation 
must be at a controlled and consistent rate that is slow enough so that the cells are not left 
without a scaffold for support. 
4.2.2 Specifications 
Certain specifications have been developed in order to achieve the optimal design. The stiffness 
gradient will range within 1 to 100 kPa. This allows all stiffness levels of the in vivo environment 
to be represented, allowing any type of cell to be cultured in this hydrogel design. The thickness 
of the hydrogel will be calculated to be 300 microns. This will prevent cell necrosis from 
occurring by allowing appropriate diffusion of nutrients and waste through the hydrogel. A 
summary of the specifications is below in Table 4.1. 
Table 4.1: Design Specifications 
Stiffness gradient range 1-100 kPa 
Hydrogel thickness 300 microns 
 
4.3 Design Alternatives 
The possible design alternatives are presented in this section of the report. First, the options for 
the polymer used to form the hydrogel are discussed. Then, the various methods for stiffness 
gradient formation are presented. 
4.3.1 Polymer Options 
The material that the hydrogel will be made of must fulfill all the mechanical and biological 
requirements for the study and survival.  There are several biomaterials that are suitable for this 
application. 
Gelatin-HPA Conjugate 
This scaffold material consists of gelatin and Hydroxyphenylproprionic Acid (HPA), which is 
then cross-linked with Hydrogen Peroxide (H2O2). This material has been shown to be highly 
biocompatible and allow for tuning of the stiffness of the final material based on the 
concentration of the cross-linker. This material is also desirable due to its fast gelation time, 
which allows for cell encapsulation.  
Cross-linked Collagen 
Collagen is another biomaterial that is often used for the formation of hydrogels. To achieve 
appropriate stiffness of the materials a cross-linking method would have to be used. Genipin is a 
highly biocompatible compound that has been used for the cross-linking of collagen and would 
be a valid cross-linking option. Another biocompatible cross-linking method of collagen is 
thermosetting. Both of these options would allow for the fine tuning of the stiffness of the 
resulting gel. 
Gelatin-Genipin 
The combination of gelatin cross-linked with genipin would also be able to fill the needs for the 
hydrogel material. This combination would be produced similarly to the collagen genipin 
combination. This option would be advantageous as only gelatin and genipin are needed to form 
this gel, meaning the hydrogel would simply be made of two compounds. This would allow for 
simpler gel formulation and fewer sources of error. 
4.3.2 Gradient Generation Methods 
The method used to make the actual gradient must create a gradient that meets the necessary 
specifications. Several different gradient generation methods have been explored. 
Dynamic Mixing: Syringe pumps at controlled rates 
This method would require the use of multiple syringe pumps and tubing sets as well as a mold 
for the gradient to be made in. Each syringe pump would hold a material of a specific molecular 
weight or percentage. As these materials are injected, the user would be able to change the rates 
so that specific ratios of the materials were being mixed together. By changing the rates for 
different pumps, it would be possible to create a higher stiffness on one side and a lower stiffness 
on the other side. As these materials were mixed, they would be injected into a mold that would 
allow the gel conjugate and cross-linker to gel. 
 
 
 
Gradient generator microfluidic mold 
This method would use a microfluidic gradient generator and a multi-port syringe pump. As seen 
in the diagram below, there would be three ports to inject different molecular weight or 
percentage conjugate/cross-linker into the microfluidic chamber. On one side, the gel with the 
lowest stiffness would be pumped through, in the middle, the gel with the medium stiffness, and 
Figure 4.1: Dynamic Mixing Sketch 
on the far side, the gel with the highest stiffness. As these gels traveled through the channels, a 
gradient would be created due to the microfluidics of the generator. 
 
 
Dynamic Flow: Gel creation with cross-linker flow through center 
With this method, a mold would be made as shown in the Figure 4.3. In each side chamber of the 
mold, a gel of a constant concentration would be created. Once this had fully gelled, tubing 
would be connected to the center channel, and cross-linker of a specific molarity would be 
flowed through. While it was flowing through this center channel, the cross-linker would diffuse 
into the hydrogel, creating a continuous gradient. The stiffest gel would be found at the inside of 
the channel and the softer gel would be found near the outside wall. 
Figure 4.2: Gradient Generator Mold Sketch 
  
 
Dynamic Flow: Gel creation with cross-linker flow down the side 
With this method, similar to the center-flowing method, a mold would be created. In the center 
chamber of the mold, gel of a constant concentration would be created and allowed to fully gel. 
Then, tubing would be connected to each side channel, and cross-linker would be flowed through 
each side. While it was flowing through, it would diffuse into the hydrogel, creating a continuous 
gradient. The stiffest gel would be found at the edge of the gel (near the cross-linker channels) 
and the softest gel would be found at the center of the gel. 
 
 
 
 
Radial cross-linker diffusion 
Figure 4.3: Dynamic Flow Middle Sketch 
Figure 4.4: Dynamic Flow Side Sketch 
In this method, the hydrogel would be poured into a circular dish and allowed to completely gel. 
After it had completely gelled, a small circular piece of gel would be removed from the center of 
the mold. In place of this, cross-linker would be injected into this center hole. Over time, the 
cross-linker would diffuse into the gel, creating a stiffness gradient. The stiffest gel would be 
found in the center, closest to the cross-linker hole. The softest gel would be found near the 
outsides of the dish, since the smallest amount of cross-linker would diffuse out there. 
 
 
Vertical diffusion 
This method would require a mold to be created in order to hold the gel and cross-linker. First, a 
gel of constant percentage would be created in the vertical diffusion mold. After the gel had 
formed, the cross-linker would be poured on top of the mold. The cross-linker would diffuse 
through the gel due to gravity, creating a stiffness gradient. The stiffest gel would be found at the 
top of the mold while the softest would be found at the bottom. 
 
 
Figure 4.5: Radial Cross-linker Sketch 
Figure 4.6: Vertical Diffusion Sketch 
4.4 Conceptual Design 
In this section of the chapter, the design alternatives presented in the previous section are 
evaluated in order to develop a final design. Methods of evaluation include a design evaluation 
matrix, group brainstorming, and the 7 Hats exercise. 
4.4.1 Design Evaluation Matrix 
After investigating all of the design options further, the team chose to reevaluate the options for 
the gradient generation method using a design evaluation matrix. The results can be seen below 
in Table 4.2. 
Table 4.2: Revised Design Evaluation Matrix for Gradient Generation Method 
Design 
Constraints  
Dynamic 
Mixing 
Convective 
Spreading 
Gradient 
Generator 
Diffusion 
Source Sink 
Between 100-
500 Microns 
Thick 
 
Y Y Y Y 
Cross-linking 
between 5-20 
minutes 
 
Y Y Y N 
Stiffness 
gradient from 
1-100 kPa 
 
Y Y Y Y 
At least 90% 
transparent  
Y Y Y Y 
          
Design 
Objectives 
Weight 
(%) Score 
W. 
Score Score 
W. 
Score Score 
W. 
Score Score 
W. 
Score 
Biocompatible 25 0.9 22.5 0.9 22.5 0.9 22.5 N/A N/A 
Continuous 
Gradient 
20 0.8 16 0.7 14 1 20 N/A N/A 
3D 20 1 20 1 20 1 20 N/A N/A 
Capable of 
Rapid 
Gelation 
15 1 15 0.8 12 0.9 13.5 N/A N/A 
Biodegradable 10 1 10 1 10 1 10 N/A N/A 
Measurable 5 1 5 1 5 1 5 N/A N/A 
Reproducible 3 0.8 2.4 0.5 1.5 1 3 N/A N/A 
Uniform 
thickness 
2 1 2 1 2 1 2 N/A N/A 
TOTAL 100 
 
94.9 
 
87 
 
96 N/A N/A 
 4.4.2 Group Brainstorming 
The following section highlights pros and cons for each alternative for gradient generation 
methods. 
Dynamic Mixing: Syringe pumps at controlled rates 
Pros Cons 
 Could specifically design according to 
desired gel percentage/stiffness 
 Good controllability of gradient 
generation 
 It’s possible that the gel/cross-linkers 
wouldn’t mix enough to create 
consistency 
 Wouldn’t know how to connect tubing to 
mold to get proper microfluidics 
Gradient generator microfluidic mold 
Pros Cons 
 It will reliably create a gradient 
 Don’t have to worry about mixing 
 Unsure of whether or not the cells will 
be affected 
 May have dimensional constraints 
Dynamic Flow: Gel creation with cross-linker flow through center 
Pros Cons 
 It’s an original idea 
 Potential to make 2 hydrogel gradients 
at a time 
 Would create an ideal gradient if it 
worked properly 
 Wouldn’t have to worry about the cells 
moving 
 Concerned that the cross-linker wouldn’t 
diffuse through the gel properly 
 Don’t fully understand the microfluidics 
of the process 
Dynamic Flow: Gel creation with cross-linker flow down the side 
Pros Cons 
 It’s an original idea 
 Would create an ideal gradient if it 
worked properly 
 Wouldn’t have to worry about the cells 
moving 
 Concerned that the cross-linker wouldn’t 
diffuse through the gel properly 
 Don’t fully understand the microfluidics 
of the process 
Radial cross-linker diffusion 
Pros Cons 
 If cross-linker diffuses properly, it’ll 
create a nice continuous gradient 
 Very quick and easy method 
 Would need to ensure the gel is viscous 
enough to not spread everywhere when 
center hole is created 
 Cross-linker may not fully diffuse 
properly 
Vertical diffusion 
Pros Cons 
 Very quick and easy method 
 Would be an easy mold to create for 
the application 
 Gravity would ideally create a good 
gradient 
 Gravity may pull cells down so that they 
are no longer evenly spaced throughout 
 If the gel cross-links on top, it’s unsure 
whether the cross-linker could still 
diffuse through the rest of the gel 
 
4.4.3 6 Hats Evaluation Method 
After brainstorming the advantages and disadvantages of each design alternative, the team 
elected to use the “6 Hats Method” to further evaluate the use of a gradient generator mold as the 
main design. The “6 Hats Method” was established by Edward de Bono and is intended for 
teams to brainstorm and evaluate an idea through the use of distinct filters. The six different 
colored thinking hats are white, red, black, yellow, green, and blue. Each color is representative 
of information, emotions, discernment, optimism, creativity, and organization respectively. A 
more detailed description of each color is described in the next paragraph. 
When using the white hat, the purpose of the exercise is to identify all available information and 
facts concerning the design method. The red hat is used to express intuitive and emotional 
feelings towards a design without providing any justifications as to why one feels a certain way. 
The black hat is used to describe any logical concerns or criticisms with the proposed design 
method. The purpose of the yellow hat is to develop logical reasons as to why the design method 
will be beneficial or advantageous. The green hat is intended to promote creativity by generating 
and building upon new ideas. Lastly, the blue hat is for mandating how the brainstorming session 
should begin and end. The blue hat is organizational thinking, meaning that before the team 
begins the process of how to proceed should be defined, and that after brainstorming the team 
must decide how to process and evaluate the results of each hat. 
The ideas generated for each hat can be found in Appendix B. After the exercise was completed, 
the team reviewed the resulting thoughts and ideas to come to a final decision on which design 
method to proceed with, which will be discussed in the following section of this chapter. 
4.5 Decisions 
After evaluating the design alternatives, the team was able to decide upon a final design. The 
team was easily able to choose a polymer for the design, as the gelatin-HPA formula guaranteed 
rapid gelation of the hydrogel—a critical aspect of the project’s design. The gradient generation 
method took more evaluation and brainstorming to decide upon. After reevaluating each design 
in a design selection matrix, the gradient generator was prominently the most fitting gradient 
generation method for the design projects needs. Upon brainstorming pros and cons for each 
design alternative, the team came to a consensus that the gradient generation method had the 
least concerning cons. Once the team further investigated each aspect of the gradient generator 
design using the 7 Hats Method, it was decided that manipulating a microfluidic generator mold 
to create a stiffness gradient would be the most feasible and promising option for the design. 
4.6 Feasibility Studies & Experiments 
In preparation for using the gelatin-HPA conjugate and the gradient generator mold as the main 
design features, certain studies and experiments are needed to determine the success of the final 
design. Before beginning any experiments, calculations were conducted to determine stock 
solutions, concentrations, and other design parameters needed to create the hydrogels. Then the 
gelation time, stiffness, and biocompatibility of these hydrogels were evaluated. 
4.6.1 Calculations 
In order to create hydrogels out of the gelatin-HPA conjugate, certain calculations were 
necessary to determine how much of each material and which concentrations would be needed. 
These calculations include finding stock solution concentrations, a 3% gelatin-HPA stock, 
determining the gel thickness in a 24-well plate, and plating a known number of cells.   
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Plating of 70,000 Encapsulated Cells: 
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4.6.2 Gelation Time Studies 
In order to determine how quickly the gelatin-HPA hydrogels would be able to fully gel, a 
gelation time study was conducted. Two microcentrifuge tubes of hydrogel solution were 
prepared in the hood according to the following protocol: 
Table 4.3: 1.5% Gelatin-HPA Hydrogels 
 
0.98 mM 
Final 
[H2O2] with 
cells 
1.47 mM 
Final 
[H2O2] with 
cells 
1.96 mM 
Final 
[H2O2] with 
cells 
No H2O2 
with cells 
1.47 mM 
Final 
[H2O2] 
without 
cells 
Gelatin-
HPA [3% 
wt] 
300 µL 300 µL 300 µL 300 µL 300 µL 
Horseradish 
Peroxidase 
6 µL 6 µL 6 µL 6 µL 6 µL 
[10 U/mL] 
(Final conc. 
10U/mL) 
10X DMEM 54 µL 54 µL 54 µL 54 µL 60 µL 
DPBS(-) 156 µL 156 µL 156 µL 180 µL 210 µL 
Cell 
Suspension 
60 µL 60 µL 60 µL 60 µL 0 µL 
H2O2 24 µL of 
24.5 mM 
H2O2 
24 µL of 
36.75 mM 
H2O2 
24 µL of 49 
mM H2O2 
None 
24 µL of 
36.75 mM 
H2O2 
Total 
Volume 
600 µL 600 µL 600 µL 600 µL 600 µL 
 
1. Dissolve gelatin-HPA powder in distilled H2O at 65°C to create a 3% weight stock 
solution. 
2. Pipette 300 µL of the 3% gelatin-HPA stock solution into a 1.5 mL microfuge tube. 
3. To #2, add 6 µL of horseradish peroxidase at a concentration of 10 Units/mL. 
4. Add 54 µL of 10x DMEM to #3. 
5. Add 156 µL of DPBS(-) to #4. 
6. To #5, add 60 µL of cells suspended in 1X DMEM. If not seeding the gel with cells, 
substitute 6 µL of 10X DMEM without cells and 54 µL of DPBS(-). 
7. To #6, add 24 µL of H2O2 (24.5 mM, 36.75 mM or 49 mM depending on desired final 
concentration). For control without H2O2, replace with 24 µL of DPBS(-) 
8. Immediately following step #7 pipette the solution up and down ten times to mix, being 
careful not to create bubbles. 
Immediately following the preparation of the hydrogel solution, the gelation time study was 
conducted for the 1.47 mM H2O2 hydrogel according to the following protocol: 
1. Pipette 150 µL of the prepared hydrogel onto each of 8 22 mm x 22 mm cover slips. Start 
a timer once all the hydrogels are pipetted onto the cover slips 
2. Starting at 6 minutes, flip one cover slip 90 degrees to a vertical position. Observe 
whether the hydrogel moves on the slide. 
3. Repeat step #2 with the remaining slides in 30-second intervals until all the slides have 
been flipped. The time at which the hydrogel does not move on the cover slip in a vertical 
position indicates the gelation time. 
The gelation time study was conducted for the 0.98 mM H2O2 hydrogel as well. For this study, 
three microfuge tubes each containing 900 µL of the hydrogel solution were prepared following 
the same protocol and ratios as above. 150 µL of hydrogel solution was pipetted onto each of 18 
cover slips. The gelation time study was conducted according to the protocol above, starting at 6 
minutes and ending at 15 minutes with a cover slip flipped every 30 seconds. 
4.6.3 AFM Baseline Stiffness Measurements 
The stiffness of gelatin-HPA hydrogels was measured using atomic force microscopy (AFM). 
For the first round of measurements, gelatin-HPA hydrogels were made at a final concentration 
of 2% gelatin-HPA. The three concentrations of H2O2 that were tested were 0.9 mM, 1.35 mM 
and 1.8 mM. APTMS treated cover slips were placed in separate petri dishes. 300 µL of the 
prepared hydrogel was pipetted onto a bottom cover slip in the petri dish. A second cover slip 
was then placed on top of the hydrogel, and the hydrogel was allowed to set for 5 minutes. The 
petri dishes with the hydrogels were covered in parafilm. The prepared hydrogels were then 
brought to Gateway for AFM measurements. Three measurements were taken at five different 
points on each gel.  
A second round of AFM measurements was conducted for gelatin-HPA hydrogels at a final 
concentration of 1.5%. These hydrogels were made with three different concentrations of H2O2: 
1mM, 1.5mM and 2.0mM. Three measurements were taken at three different points on each gel. 
4.6.4 Biocompatibility of Polymer Assessment 
In order to determine the biocompatibility of the gelatin-HPA conjugate, cells were cultured 
under several conditions and then imaged every other day. Hydrogels were prepared in duplicate 
at 1.5% gelatin-HPA conjugate for both NIH 3T3 Mouse Fibroblasts and for Human Primary 
Fibroblasts. The conditions used were as follows: 
H2O2 Concentration: 0mM, 1mM, 1.5 mM, 2mM 
 Cells encapsulated: 150,000 cells 
 Cells seeded on the surface: 100,000 cells 
Controls: Cells cultured on the polystyrene well surface 
 50,000 cells 
 100,000 cells 
 The hydrogels and controls were prepared in a 24 well plate using the following protocol: 
 Table 4.4: 1.5% Gelatin-HPA Hydrogels 
 1 mM 
Final 
[H2O2] 
with cells 
1.5 mM 
Final 
[H2O2] 
with cells 
2 mM 
Final 
[H2O2] 
with cells 
0mM 
H2O2 
with cells 
50,000 
Cells 
100,000 
Cells 
Gelatin-
HPA [3% 
wt] 
150 µL 150 µL 150 µL 150 µL None None 
Horseradish 
Peroxidase 
[10 U/mL] 
(Final conc. 
10U/mL) 
3 µL 3 µL 3 µL 3 µL None None 
10X DMEM 27 µL 27 µL 27 µL 27 µL None None 
DPBS (-) 78 µL 78 µL 78 µL 90 µL None None 
Cell 
Suspension 
30 µL 30 µL 30 µL 30 µL 30 µL 30 µL 
H2O2 12 µL of 
24.5 mM 
H2O2 
12 µL of 
36.75 mM 
H2O2 
12 µL of 
49 mM 
H2O2 
None None None 
Total 
Volume 
300 µL 300 µL 300 µL 300 µL 60 µL 60 µL 
 
1. Dissolve gelatin-HPA powder in distilled H2O at 65°C to create a 3% weight stock 
solution. 
2. Pipette 150 µL of the 3% gelatin-HPA stock solution into each well of a 24 well plate, 
leaving 2 columns empty for the controls. 
3. To #2, add 3 µL of horseradish peroxidase at a concentration of 10 Units/mL, leaving the 
control wells empty. 
4. Add 27 µL of 10x DMEM to #3, leaving the control wells empty. 
5. Add 78 µL of DPBS(-) to #4 for the 1 mM, 1.5 mM, and 2 mM concentrations. Add 90 
µL to the 0 mM concentrations, and leave the control wells empty. 
6. To #5, add 30 µL of cells suspended in 1X DMEM.  
7. To #6, add 12 µL of H2O2 (24.5 mM, 36.75 mM, 49 mM, or none depending on desired 
final concentration). 
8. Immediately following step #7 pipette the solution up and down ten times to mix, being 
careful not to create bubbles. 
9. Leave the hydrogels in the hood to cross-link for 30 minutes. 
10. After 30 minutes, gently pipette 500 µL of cell culture media into each well. 
11. Store the culture plates in the 37C 5% CO2 incubator. 
After 24 hours of incubation, both the plates of NIH 3T3 Mouse Fibroblast cells and the Human 
Primary Fibroblast cells were imaged using a phase contrast microscope at 20X magnification. 
Additional images were also taken of each condition at 36 and 52 hours.  
4.7 Modeling 
A model system was used to illustrate the process of gradient formation through the generator. 
First DPBS was used as the primary solution that was flowed through the channels to confirm 
that the fluid flowed correctly through the mold. Concentrated dyes were then added to the water 
in the syringes connected to the outermost channels of the generator. The dyes visually 
confirmed the presence of a gradient within the gradient-formation well.  
4.8 Preliminary Data 
Data obtained from feasibility studies and experiments are included in this section of the report. 
Quantitative and qualitative results are included for the gelation time studies, the AFM baseline 
stiffness measurements, and the biocompatibility study. 
4.8.1 Gelation Time Data 
1.5% Gelatin-HPA 1.96 mM H2O2 
The baseline experiment for the gelation time of 1.96 mM H2O2 cross-linked hydrogels 
determined that the hydrogel completely gelled within 10 minutes. In the gelation study, the first 
coverslip was flipped vertically 2:00 minutes after the timer was started. A total of 5 coverslips 
were flipped at 30-second intervals. The 1.96 mM H2O2 cross-linked hydrogels fully gelled at 4 
minutes. The resulting vertical coverslips can be seen in the image below. 
 
Figure 4.7: 1.96 mM H2O2 Gelation Results 
 
 
1.5% Gelatin-HPA 1.47mM H2O2 
The baseline experiment for the gelation time of 1.47 mM H2O2 cross-linked hydrogels 
determined that the hydrogel completely gelled within 10 minutes. In the gelation study, the first 
coverslip was flipped vertically 6:00 minutes after the timer was started. A total of 12 coverslips 
were flipped at 30-second intervals. The 1.47 mM H2O2 cross-linked hydrogels fully gelled at 
8:30 minutes. The resulting vertical coverslips can be seen in the image below. 
 
Figure 4.8: 1.47 mM H2O2 Gelation Results 
 
1.5% Gelatin-HPA 0.98mM H2O2 
The baseline experiment for the gelation time of 0.98 mM H2O2 cross-linked hydrogels 
determined that the hydrogel did not completely gel within 10 minutes. In the gelation study, the 
first coverslip was flipped vertically 6:00 minutes after the timer was started. A total of 16 
coverslips were prepared to be flipped at 30-second intervals. The first two coverslips were 
completely liquid, and therefore the first coverslip was not flipped until 7:00 minutes into the 
experiment. The 0.98 mM H2O2 cross-linked hydrogels fully gelled at 14 minutes. The resulting 
vertical coverslips can be seen in the images below. 
 
Figure 4.9: 0.98mM H2O2 Gelation Results 
 
4.8.2 Stiffness of Preliminary Samples 
The average stiffness of the samples measured using AFM are organized in the table below.  
Table 4.5: Preliminary AFM Measurements 
Gtn-HPA H2O2 (mM) Average Stiffness Standard Deviation 
2%  
1.8 mM 354.72 Pa ± 199.7 Pa 
1.35 mM 424.18 Pa ± 424.1 Pa 
0.9 mM 260,886.09 Pa ± 237,402.1 Pa 
1.5% 
2 mM 620.50 Pa ± 308.5 Pa 
1.5 mM 285.50 Pa ± 382.9 Pa 
1 mM 1,382,931.86 Pa ± 2,548,988.2 Pa 
 4.9 Optimization 
After developing the design further, some adjustments were needed to achieve the desired 
functions and specifications.  
4.9.1 Additional AFM Measurements 
Preliminary AFM measurements revealed that the samples tested did not fulfill the entire 
stiffness range of 1 to 100 kPa. To create stiffer gels, the team decided to test hydrogels using a 
higher percentage of gelatin-HPA and a higher concentration of the H2O2 cross-linker. The team 
conducted additional AFM experiments on the gels outlined in Table 4.6. 
Table 4.6: Additional AFM Measurements 
Gtn-HPA H2O2 (mM) Average Stiffness Standard Deviation 
2%  
1.5 mM 1,753 Pa ± 2,540,472 Pa 
2.0 mM 1,056 Pa ± 560 Pa 
2.5 mM 1,364 Pa ± 484 Pa 
3.0 mM 1,108 Pa ± 352 Pa 
3.5 mM 1,333 Pa ± 531 Pa 
1.5% 
1.5 mM 277 Pa ± 140 Pa 
2 mM 357 Pa ± 89 Pa 
2.5 mM 318 Pa ± 87 Pa 
3.0 mM 482 Pa ± 452 Pa 
3.5 mM 988 Pa ± 856 Pa 
4.9.2 Hydrogel Formula Modifications 
Upon additional review the hydrogel formula, the amounts of reagents were recalculated to 
provide greater accuracy of stock concentrations.  The recalculated formula is listed in Table 4.7. 
Table 4.7: Revised Gelatin-HPA Hydrogel Formula 
 1% Gtn-HPA 1.5% Gtn-HPA 2% Gtn-HPA 
Gtn-HPA [3% wt] 40 µL 60 µL 80 µL 
HRP [10 U/mL] 5 µL 5 µL 5 µL 
DPBS (+) 45 µL 25 µL 5 µL 
Cells in 10X DMEM 24 µL 24 µL 24 µL 
H2O2 6 µL  6 µL  6 µL 
Total Volume 120 µL 120 µL 120 µL 
New stock solutions were diluted from a 1 M H2O2 solution in order to create the final H2O2 
concentrations listed in Table 4.8. 
Table 4.8: Revised H2O2 Stock Solutions 
Final H2O2 Concentration Stock Concentration 
1 mM 20 mM 
1.5 mM 30 mM 
2 mM 40 mM 
2.5 mM 50 mM 
3 mM 60 mM 
3.5 mM 70 mM 
 
4.9.3 Additional Gelation Time Studies 
After making alterations to the hydrogel formulas, additional gelation time studies were 
conducted for 1%, 1.5%, and 2% gtn-HPA hydrogels at 1 to 3.5 mM H2O2 concentrations.  
These studies were completed using an alternative method from the initial gelation studies. The 
hydrogels were made using the formulas from Table 4.7, but by following the procedure outlined 
in Appendix C. The total volume created of each combination was 120 uL, and two 50 uL drops 
were placed in petri dishes. A timer was started when the hydrogen peroxide was added to the 
HPA solution. Then the drops were inspected both visually, as the drops would become cloudy 
during gelation, and also physically, as upon completion of gelation it is no longer possible to 
draw the gel into a pipette tip. The test gels can be seen in Figure 4.10. The 2.0% gels appeared 
to have the most opaque appearance, possibly as a result of containing the highest extent of 
cross-linking. In addition to this they had the quickest gelation times for each respective 
hydrogen peroxide concentration used.  
 Figure 4.10: Test gels for 1%, 1.5%, and 2% gelatin-HPA. 
A direct relation can be seen between an increase in the concentration of both gelatin and 
hydrogen peroxide and an in increase in the rate of gelation. The data found can be seen 
displayed in Figure 4.11; in addition this information is available in the table found in Appendix 
I. 
 
Figure 4.11: Gelation time data 
  
Chapter 5: Design Verification 
The raw results of each validation experiment are presented in this chapter. Data was collected 
from AFM measurements of baseline hydrogels, microscopy of a gradient containing fluorescent 
dye, and observations from cell biocompatibility and behavior studies. 
5.1 Baseline AFM measurements 
In Chapter 4, preliminary results were reported for baseline single-stiffness Gelatin-HPA 
hydrogels. However, these results did not achieve the optimal level of stiffness for the 1 to 
100kPa gradient. Additional baseline AFM measurements were taken for 1.5% and 2% Gelatin-
HPA hydrogels with cross-linker H2O2 concentrations 1.5, 2, 2.5, 3, and 3.5 mM. Three samples 
were prepared for each testing condition, and three AFM measurements were conducted in three 
different points of each sample. All AFM data is available in Appendix J. All of the data found in 
Appendix J was averaged to obtain the following plot. 
 
 
Figure 5.1: Average AFM Measurements for Gtn-HPA Hydrogels. 
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5.2 Validation of Gradient Creation Components 
This section presents the validation of gradient creation within the gradient generator as well as 
the validation of cell flow throughout the gradient generator system. 
5.2.1 Validation of Gradient 
To ensure that a gradient could be created with the microfluidic gradient generator, water was 
mixed with basic food dye and was run through the system. As seen in the figure below, the 
gradient generator device did indeed create a gradient with the water and food dye. 
 
Figure 5.2: Gradients generated with water and food dye 
In the figure above, the right image shows the water and food dye as it flows through the 
gradient maker and mixes together until reaching the final well. The left image shows the water 
and food dye gradient that was created from this flow system. The stiffness bar shows that the 
increasing food dye represents the increasing stiffness in a gel. 
5.2.2 Validation of Cell Flow 
To test if cells were able to flow with ease through the gradient generator, cells were mixed with 
complete media, loaded into syringes, and were pumped through the system using a syringe 
pump. The image shown in Figure 5.3 is captured from a video taken of the cells flowing 
through the system. 
 Figure 5.3: Cells Flowing through Gradient generator. The right shows the location of the 
flow testing within the system and the left shows an image of the cells moving through the 
system. 
While viewing the video, it was determined that there was no problem with cells flowing through 
the system. As seen in the image above, the cells seemed to flow quite easily through the system 
and did not appear to block any of the system. This test proved that cell flow through the 
gradient generator would be simple and would not interfere with any gradient creation. 
5.3 Gradient Creation and Visualization 
Once gradient creation and cell flow within the generator were validated, the next step was to 
create the actual 3D hydrogel with a stiffness gradient and encapsulate cells within it. 
5.3.1 Creation of Gradient with Conjugates 
Following the Standard Operating Procedure in Appendix H, three gel concentrations were 
flowed through the microfluidic generator to create a gradient. The following table shows which 
gel conjugate percentage and concentration was in each of the syringes. 
 Figure 5.4: Gelatin-HPA percentage and H2O2 concentration in each syringe 
The syringe pump ran at a flow rate of 15 μL/min for approximately 3 minutes to make the 
gradient-hydrogel. After this time was complete, the following image was taken of the resulting 
gel. It is important to note that syringe 1 had no food dye, syringe 2 had the 50% food dye mixed 
in, and syringe 3 had the 100% food dye mixed in. 
 
Figure 5.5: Gelatin-HPA with H2O2 Gradient Gel ranging from softer to stiffer 
As seen in the figure, the ranging gradient of blue food dye within the gel is representative of the 
stiffness level of the gel. The figure shows that the creation of a three dimensional hydrogel 
system with a continuous stiffness gradient is possible with the use of a microfluidic gradient 
generator. 
5.3.2 Encapsulation of Cells within Gradient 
Once it was determined to be possible to create a 3D hydrogel with a stiffness gradient, cells 
were then encapsulated inside of the 3D environment. Cells were mixed in the gel concentrations 
listed above in Figure 5.4 and the system was run according to the same protocol. Again, after 3 
minutes, the system was stopped and the gel was allowed enough gelation time. After this time 
was up, the gradient-hydrogel was imaged. The following figure shows cells encapsulated within 
the gradient gel. 
 
Figure 5.6: Cells encapsulated within the 3D Hydrogel with a stiffness gradient 
The figure above shows that some cells are in focus in the image while others are not completely 
in focus. This tells viewers that the cells are in different planes of the gel, meaning that they are 
encapsulated in a three dimensional environment within the gel.  
With the creation of a gradient and the encapsulation of cells, the final goal of the project was 
completed; to create a three dimensional hydrogel system with a continuous stiffness gradient for 
the encapsulation of cells. 
5.3 Cell Culture 
In Chapter 4 the results of a preliminary cell biocompatibility and behavior study were reported. 
After modifying the hydrogel formulas, the team decided to conduct a second study using the 
following formulas: 
 1.5% and 2% Gelatin-HPA 
o 1, 1.5, 2, 2.5, 3, 3.5 mM H2O2 
For this study NIH 3T3 Mouse Fibroblasts, Primary Human 2097 Fibroblasts, STO Mouse 
Embryonic Fibroblasts, and Mouse Embryonic Stem Cells were each cultured in 96-well plates. 
Each plate was prepared with the following conditions: 
 Cells encapsulated in hydrogel (100,000 cells) 
 Cells seeded on the surface of hydrogel (2,000 cells) 
 Cells seeded directly onto the polystyrene well (2,000 cells) 
5.3.1 Cell Culture 
After imagine the cells at Day 0, the cells were imaged every three days. The first figure shows 
images taken of the 3T3 Mouse Fibroblasts. 
 
Figure 5.7: Mouse Fibroblast cells (3T3) in 3D Gel 
NIH 3T3 mouse fibroblasts encapsulated in the hydrogels (1.5% gtn-HPA 1.5 mM H2O2, 2% 
gtn-HPA 1.5 mM H2O2, and 2% 3.0 mM H2O2) and plated on polystyrene as a control both 
showed small balled morphologies at day 0 imaging, indicative of recent plating. By day 3, some 
spreading was visible among all conditions. By day 6, the control polystyrene wells showed high 
confluency in comparison to the encapsulated cells. Some dark cells can be seen in the 2% gtn-
HPA 1.5 mM H2O2 and 2% gtn-HPA 3.0 mM H2O2 conditions, indicating cell death. By day 9, a 
large amount of cells can be seen spread throughout the hydrogels. 
Next, the following figure shows the 2097 Primary Human Fibroblast cells over the course of the 
experiment. 
 
Figure 5.8: Primary Human Fibroblast cells (2097 line) in 3D Gel 
2097 primary human fibroblasts encapsulated in the hydrogels (1.5% gtn-HPA 1.5 mM H2O2, 
2% gtn-HPA 1.5 mM H2O2, and 2% 3.0 mM H2O2) and plated on polystyrene as a control both 
showed small balled morphologies at day 0 imaging as well, indicative of recent plating. At day 
3, some of the encapsulated cells remain balled while some can be seen spreading through the 
gel and extending narrow protrusions. The control cells can be seen spreading and developing 
thicker protrusions. By day 6, some dark cells can be seen across all cell conditions indicating 
minimal cell death. By day 9, the encapsulated spread cell can be seen overlapping each other, 
forming a grid-like pattern. Significant amounts of spreading can be seen in the control cells at 
day 9.    
Finally, the results for the STO embryonic mouse fibroblast cell line are shown in the figure below.
 
Figure 5.9: Mouse embryonic fibroblast cell line (STO) in 3D gel 
STO embryonic mouse fibroblasts encapsulated in the hydrogels (1.5% gtn-HPA 1.5 mM H2O2, 
2% gtn-HPA 1.5 mM H2O2, and 2% 3.0 mM H2O2) and plated on polystyrene as a control both 
also showed small balled morphologies at day 0 imaging, indicative of recent plating. By day 3, 
the encapsulated cells can be seen very clearly in 3D beginning to spread throughout the 
hydrogel. By day 6, the cells show similar morphologies to the previous imaging period. The 
polystyrene control shows a high confluency of cells, indicating the proliferation of cells. 
 
  
Chapter 6: Discussion 
In this chapter, the results for AFM measurements, gradient visualization, cell biocompatibility, 
and cell behavior are analyzed and discussed.  
6.1 Gelatin-HPA Hydrogel Stiffness 
Data from the AFM measurements showed that an increase in cross-linker concentration from 
2mM to 3mM H2O2 resulted in an increase in gelatin-HPA hydrogel stiffness. After the 3mM 
H2O2 concentration, an increase in H2O2 concentration resulted in decreased stiffness. At this 
high concentration of H2O2 it is likely that the gelatin-HPA becomes fully saturated with cross-
links produced by the H2O2. The gelatin-HPA hydrogel is formed through an enzyme-mediated 
oxidative coupling reaction. The H2O2 plays a role in determining the hydrogel stiffness while 
the HRP determines the gelation rate. The data suggest that at 3 mM H2O2 the optimal amount of 
available phenol groups are coupled into cross-links, forming the stiffest possible hydrogel. At 
H2O2 concentrations greater than 3 mM, additional H2O2 creates an excess of cross-linking 
chains, which diminishes the mechanical properties of the hydrogel. 
The stiffness levels that were achieved ranged from 300 Pa (1.5% gtn-HPA, 1mM H2O2) to 1500 
Pa (2% gtn-HPA, 3.5mM H2O2). Reported values from previous 2% gelatin-HPA hydrogel 
studies conducted by Wang et al. (2012) showed a stiffness range from 20 to 1000 Pa for H2O2 
concentrations ranging from 0.5 mM to 1.7 mM. These reported values are very similar to the 
values achieved through the AFM analysis conducted for the team’s design.  
While the AFM measurements provided data that identified the range of achievable stiffness, 
there are several limitations that should be considered when evaluating the data. The methods for 
hydrogel creation introduce a level of variability in the AFM results. The gelatin-HPA hydrogel 
is formed through a chemical cross-linking reaction. In order for the gel to be completely 
uniform, it must be thoroughly mixed before pipetting onto coverslips for AFM. Any user error 
in mixing can result in a hydrogel with variable stiffness. Some of the hydrogel samples that 
were measured showed high standard deviations between each sampling point. For the purpose 
of data analysis, any extreme outliers (standard deviation > 2,000) were removed from averages. 
 
6.2  Gradient Visualization 
With the assistance of basic food dye, it was possible to view that a continuous gradient was 
created using the microfluidic gradient generator. The range of food dye color represents the 
range of stiffness across the hydrogel.  
Through various trials, the team was able to flow the Gelatin-HPA with hydrogen peroxide 
through the system in order to create a gel with a stiffness gradient. More impressively it was 
found to be possible to flow cells through the gradient generator with the gel precursors, 
ultimately creating the final goal of a 3D, cell encapsulating hydrogel with a continuous stiffness 
gradient. Through the successful incorporation of cells, the team showed that it is indeed possible 
to suspend the cells in a 3D culture system using the design methods. 
Throughout the studies, a few limitations of the system were determined. First, the camera on the 
microscope used for imagining did not have a high enough resolution. This made it difficult to 
capture cell flow and gradient creation. Next, it was determined that the gradient was easiest to 
create before the addition of the cross-linker. Although this is beneficial for visualization 
purposes, the cross-linker is necessary to reach full gelation and properly suspend cells in 3D. It 
would be ideal if this part of the system could be refined so that gelation can fully occur without 
clogging gradient channels. Also, when the cross-linker was added prior to flowing the system, 
the time period for flow was limited to about 3 minutes due to the rapid gelation time of the 
conjugates. The team needed to mix the conjugates and set up the system very time efficiently in 
order to create a high quality gradient-hydrogel, which was challenging. Finally, bubbles 
disturbed the gradient on multiple occasions. While preparing the gradient generator mold and 
setting up the system, there was always a risk of air bubbles getting inside the system. Once air is 
trapped within the mold it is almost impossible to remove. It would be beneficial to create a 
method for prevention or removal of trapped air so that the gradient is not altered by air bubbles 
in the future. 
6.3 Cell Biocompatibility 
The gelatin-HPA hydrogel was anticipated to show biocompatible results, as gelatin is naturally 
experienced in vivo. However, a concern that was the H2O2 could adversely affect cell viability 
above a certain concentration. The 2-week cell study showed that cells encapsulated within the 
hydrogels thrived. Cells that were seeded on the hydrogel surface thrived all H2O2 concentrations 
except the 3 and 3.5 mM. Dead cells were seen in the 3 and 3.5 mM concentrations starting at 
day three, and by day twelve all cells in the 3 and 3.5 mM concentrations were dead. 
Studies conducted by Wang et al (2012) showed that there was a high tolerance towards H2O2 
for aNSCs encapsulated within gelatin-HPA hydrogels. Experiments showed that the viability of 
aNSCs did not change when exposed to H2O2 concentrations up to 200 µM. At 500 µM the 
aNSCs showed apparent cell death. The team used H2O2 concentrations ranging from 1 to 3.5 
mM (1000 to 3500 µM). In comparison, the results of the biocompatibility study suggest that the 
cells were able to withstand a much higher concentration of H2O2 than in previous studies. 
AFM measurements revealed that at 3 mM H2O2 the hydrogel becomes fully saturated with 
cross-links, meaning that at increased concentrations there is remaining unused H2O2. The most 
likely reason for the cell death occurring for the cells seeded on the surface of the hydrogels is 
because the excess H2O2 is leeching out from the gel into the media. In future studies, the 
hydrogels should be rinsed with DPBS several times before seeding the cells in order to remove 
the excess H2O2. 
6.4 Cell Behavior 
The cell behavior studies showed significant differences in the morphologies of the cells seeded 
within the hydrogels in comparison to those that were controls on the polystyrene plates. Often in 
the hydrogels an assortment of morphologies were seen. Within a single hydrogel there was a 
variance in morphologies as some cells maintained small balled morphologies while others 
showed significant spreading. 
Observations indicated a high rate of cell death in 1.5% and 2.0% hydrogels with a 3.5mM H2O2 
concentration. However, cells in the hydrogels cross-linked with lower H2O2 concentrations 
thrived. Despite the issue with toxicity in the hydrogels with 3.5mM H2O2 concentrations, the 
cells encapsulated and seeded atop the gels with lower concentration appeared to have a high rate 
of survival. This conclusion was drawn by visual inspection of the plate. The cells were plated at 
a low density, allowing for the easy observation of individual cell morphology to assess whether 
or not the cells were alive and attached to the substrate. Inspection of the culture plates showed 
that during the cell study period, the media continually turned yellow, suggesting cell survival 
and proliferation. In the plates containing human fibroblasts and mouse fibroblasts, there were 
significant amounts of living cells at the end of the two-week study. 
Cell behavior studies conducted on aNSCs showed decreased proliferation in all gelatin-HPA 
hydrogels, with the highest cross-linking densities showing the most extreme difference. The 
team observed that the encapsulated cells were proliferating, however attempts at conducting a 
BrdU assay to quantify proliferation were unsuccessful. In some culture plates, the stains were 
unable to diffuse through the hydrogel, while in others the stained images were difficult to focus 
on through the 3D hydrogel. 
Wang et al. (2012) found that aNSCs encapsulated in gelatin-HPA hydrogels differentiated into 
neurons and astrocytes when exposed to certain stimuli. It was found that for the aNSCs the 
density of the cross-linking did not significantly affect differentiation. The team cultured eMSCs 
on the surface of the gelatin-HPA hydrogels, but differentiation was not observed. 
There are several limitations that should be considered when analyzing the cell studies. A major 
challenge was the inability to count the cells once they were suspended in 3D. It is not possible 
to extract the cells from the cross-linked hydrogel, and there are no distinguished methods for 
counting cells within a 3D hydrogel. Until a method can be established to remedy this issue, it 
will be extremely challenging to obtain accurate counts of the cells within 3D hydrogels. 
Another challenge with the culturing of the hydrogels is the replenishment and removal of media 
from the wells. Aspiration using a Pasteur Pipette does not allow for the necessary precision and 
control and is therefore not an option, however even the use of a micropipette can be concerning.  
As the softer hydrogels spend more time suspended in media, they swell and become more likely 
to be accidently aspirated into a pipette when removing depleted media. For this reason, it is 
important to keep careful records of what amount of media was added to each well to avoid 
unintentional removal of the hydrogels. Finally, many staining procedures that are currently used 
are not adapted to use for cells suspended with a medium. When staining cells, it is necessary to 
account for the time necessary for the stain to be able to diffuse through the hydrogel to the cells.   
6.5 Design Considerations  
6.5.1 Economics 
After additional refinement, the design could become a patented cell culture system available to 
biomedical research companies. This would introduce competition within current cell culture 
techniques used for biomedical research and would promote the development of additional 3D 
culture systems that better represent in vivo stiffness levels. 
6.5.2 Environmental Impact 
The creation of the design will have little impact on the natural environment. The hydrogels form 
through a cross-linking reaction that does not release harmful toxins into the environment. All 
design preparation and experiments must be conducted in a laboratory, so there is no direct 
impact on the outside environment. 
6.5.3 Societal Influence 
By allowing for the creation of in vitro models more reflective of conditions within the body, the 
design could potentially lead to the discoveries of new treatments and cures for various medical 
conditions. This can ultimately lead to a healthier population. 
6.5.4 Political Ramifications 
The design has the potential to revolutionize cell culture methods by making them more 
representative of in vivo conditions, meaning that any stakeholders investing in use of the culture 
system described in this report could increase the value and integrity of their company. The 
design pertains to cell culture with various cell types, and can therefore be applied to clinical 
circumstances such as the co-culturing of cells, the development of organoids for in vitro drug 
testing, and the culturing of patient derived cells. Having wide variety of clinical applications, 
the 3D hydrogel system containing a realistic stiffness gradient can be used for research by 
companies on a global scale. 
6.5.5 Ethical Concern 
A major application of the design would be in the study of stem cells to see their behavior at a 
range of stiffness within the body. This application could produce some controversy. However, 
the benefits that could result from using stem cells to develop new methods of treatments may 
outweigh this ethical conflict. 
6.5.6 Health and Safety Issues 
There are little safety concerns involving the design. However, the design involves the use of 
biological materials and therefore must be handled in a biosafety cabinet. Any chemicals must be 
disposed of in a biohazardous waste bin as appropriate. If the user disposes of hazardous 
chemicals improperly, for example down the drain, then there could be a potential negative 
impact on the environment as the chemicals would then be introduced into the local water 
supply.  
6.5.7 Manufacturability 
The design could eventually be manufactured, which would produce a marketable product. 
Currently, the design would need to be manufactured as a kit. The kit would include the gelatin-
HPA conjugate, the gradient generator mold, and any small features such as syringes and tubing 
that are necessary for the design. Instructions provided with the kit would allow for others to 
create their own 3D stiffness gradient-hydrogel systems. 
6.5.8 Sustainability 
The hydrogel system is composed largely from the natural polymer gelatin. Gelatin occurs in 
living organisms, meaning that, unlike synthetic polymers, it can be easily derived without 
exhausting resources for synthesis.  
6.6 Financial Considerations  
The financial considerations were analyzed to determine the cost associated with making a single 
gradient gel from the microfluidic gradient generator. First, the costs to make one gel conjugate 
batch from a full preparation were determined. Following the scaled-down version of the 
protocol in Appendix C, the following cost chart (Figure 6.1) was created for a gel conjugate 
preparation. 
 Figure 6.1: Gel Conjugate Preparation Costs 
From this analysis, it was determined that it takes $125.78 to produce 1.5806 grams of gelatin-
HPA conjugate. A single gradient-hydrogel uses 960 μL of gelatin-HPA conjugate. The cost to 
make a single 960 μL gel was derived through further calculations. Figure 6.2 shows this 
analysis, based off of the 1.5% gels made using the protocol in Appendix D. 
 
Figure 6.2: Cost Analysis for the Creation of Gradient Gels 
From this analysis, it was determined that 960 μL of a 1.5% gel could be created for $1.19. 
Next, the gradient generator creation and preparation costs were analyzed. These costs can be 
found in the Figure 6.3. 
 Figure 6.3: Cost Analysis for the Gradient Generator Creation 
From this analysis, it was determined that a gradient generator costs $3.00 to make.  
The total cost of the gradient gel system was calculated based on these analyses. Since each 
gradient gel requires the use of three separate 960 μL gels and one gradient generator, the total 
cost is as follows: 
 
As seen above, the total cost of the gradient generator system is $6.57. 
 
 
  
Chapter 7: Final Design and Validation 
This chapter describes how each of the design aims were met, and how the project was 
conducted. The final, validated design is described in detail. 
7.1 Final Design 
The final design consists of a gelatin-HPA conjugate hydrogel, a microfluidic gradient generator, 
and a syringe pump system (Figure 7.1). The gelatin-HPA hydrogel as described by Wang et al. 
(2012) was chosen for the hydrogel system because it is biocompatible, biodegradable, 
transparent enough to image cells, easily tunable mechanically, and can be cross-linked without 
compromising cell viability. The microfluidic gradient generator was chosen as the method for 
gradient formation because it creates a continuous gradient, allows for cells to pass through the 
channels, and is capable of mixing various concentrations.  
 
Figure 7.1: Final Design Methods 
7.2 Design Methods 
The following sections describe the methods that were followed in order to achieve the final 
design.  
7.2.1 Hydrogel Preparation  
The gelatin-HPA conjugate was synthesized following Wang et al.’s procedure, described in 
Appendix C. All reagents were mixed and maintained at a pH of 4.7, dialyzed against salt water, 
ethanol, and water, and lyophilized. In order to create gelatin-HPA hydrogels of certain 
concentrations, a stock mixture of 3% gelatin-HPA was created. Table 7.1 summarizes the 
calculated formulas for 1%, 1.5%, and 2% gelatin-HPA dilutions. 
Table 7.1: Gelatin-HPA Hydrogel Formulas 
Reagents 1% 1.5% 2% 
1. Gelatin-HPA (3% Stock) 40 μL 60 μL 80 μL 
2. HRP (10 U/mL) (Final conc. 0.1 U/mL) 5 μL 5 μL 5 μL 
3. DPBS (+) 45 μL 25 μL 5 μL 
4. 10X DMEM Cell Suspension 24 μL 24 μL 24 μL 
5. H2O2 6 μL 6 μL 6 μL 
 
When mixing the hydrogel precursors, each reagent was warmed to 30 °C. Hydrogel precursors 
were mixed in microcentrifuge tubes. The order that each reagent was added when mixing the 
hydrogel precursors was important. The reagents were added following the sequence outlined in 
Table 7.1. To achieve varied stiffness, different H2O2 stock solutions were used (Table 7.2). 
After adding the H2O2, the gel precursors were mixed 4 times by pipetting up and down with a 
100 μL pipette. A detailed procedure for preparing the hydrogels is located in Appendix D. 
Table 7.2: H2O2 Stock Solutions 
Final H2O2 Concentration Stock Concentration 
1 mM 20 mM 
1.5 mM 30 mM 
2 mM 40 mM 
2.5 mM 50 mM 
3 mM 60 mM 
3.5 mM 70 mM 
 
7.2.2 Gradient Generator Preparation 
Microfluidic gradient generators were prepared following the protocol outlined in Appendix E. 
Molds were created from silicone wafers using PDMS. In order to provide adequate surface 
tension in the microfluidic channels, a glass coverslip was plasma bonded over the mixing 
portion of the mold. When plasma bonding the glass to the PDMS, it was crucial that both parts 
were completely clean and dust free. In order to create a full, permanent plasma bond it is 
important not to touch any of the treated area when handling the plasma treated glass. To finish 
preparing the gradient generator for flowing, a second glass coverslip was cleaned and pressed 
firmly onto the area of the generator where the gradient forms. To seal the system, a piece of 
Scotch tape was pressed firmly onto the area where the two glass coverslips meet.  
7.2.3 Stiffness Validation 
Stiffness of the hydrogels was measured using the AFM protocol outlined in Appendix F. 
Gelatin-HPA hydrogels were formed on treated coverslips the day of AFM testing. The gels 
were allowed to cross-link for 30 minutes before the top coverslip was removed. DPBS was 
added and the hydrogels were hydrated for 15 minutes before being measured. For each sample, 
three measurements were taken at three random points across the gel’s surface. The data was 
then analyzed using a MATLAB script provided by WPI Graduate Student, Gawain Thomas.  
7.2.4 Flow Methods 
The flow methods used to create gradient-hydrogels are outlined in detail in Appendix H. When 
flowing the gradient-hydrogel, three different hydrogel combinations were mixed into 
microcentrifuge tubes. In order to visualize the gradient, concentrated dyes were used in place of 
the DPBS (+) for validation experiments. The concentrations used were: 1.5% gtn-HPA with 3.0 
mM H2O2, 2% gtn-HPA with 1 mM H2O2, and 2% gtn-HPA with 3.0 mM H2O2. Once the H2O2 
was added to the tubes, syringes were loaded with each individual combination. After removing 
any air bubbles, locking the syringes in place, and attaching the tubing, flow was started at a rate 
of 15 μL/min (Figure 7.2). After about 3 minutes of flowing, the hydrogels fully cross-linked and 
a gradient was visible (Figure 7.3).  
 Figure 7.2: Syringe Pump Setup 
 
Figure 7.3: Gradient Illustration 
 
  
Chapter 8: Conclusions and Recommendations 
The 3D hydrogel system with a continuous stiffness gradient developed for this project has been 
fully developed conceptually. While many validations have proved that the concept will yield a 
functional 3D hydrogel system, the stiffness of a gradient-hydrogel has not yet been measured. 
To conclude, final points and recommendations for future work are discussed in this chapter.  
8.1 Conclusions 
The team has developed methods that allow for cells to be encapsulated in a 3D hydrogel with a 
continuous stiffness gradient. The design incorporates a biocompatible cross-linking method for 
a hydrogel that gels rapidly within 3 to 10 minutes, allowing for 3D suspension of cells. The 
gelatin-HPA hydrogel was easily modified to achieve stiffness levels that surpass those of 
previous studies, allowing for 300 to 1500 Pa to be represented in the gradient. The gradient was 
validated to be continuous by using concentrated dyes and microscopy, and the biocompatibility 
and the dimensionality of the hydrogel were validated through a cell culture study.  
Traditional cell culture methods do not accurately reflect conditions natively experienced by 
cells, and can therefore not be used as clinical models. This 3D hydrogel system has the potential 
to revolutionize cell culture techniques. By encapsulating cells in a biocompatible, 3D 
environment, cells can interact with one another, develop morphologies, and proliferate at a rate 
more representative of how they would behave naturally within tissue. The 3D gelatin-HPA 
hydrogel with a stiffness gradient from 300 to 1500 Pa allows for cell cultures to be conducted in 
a substrate with a more realistic stiffness level and dimensionality reflective of in vivo 
conditions.  
While the gradient 3D hydrogel system provides a highly representative in vitro model for cell 
culture, there are several challenges associated with common use of this design. In particular, it 
is difficult to focus on cells when imaging a 3D culture because encapsulated cells are suspended 
throughout various layers of the hydrogel. For this project, videos were taken to easily view cells 
in all levels of focus. However in order for 3D systems to become a mainstream cell culture 
technique, imaging methods must be more thoroughly established.  
This 3D hydrogel system approach can be a used as an in vitro model system to study changes in 
a multitude of cell behavior as they respond to changes in substrate stiffness in a 3D 
environment. This design allows for the production of hydrogels engineered to assist in the 
development of tissue-engineered scaffolds that mimic biomechanical properties specific to 
tissues for a wide range of clinical applications. Stiffness gradients can occur naturally within 
tissues, or from pathological causes such as tumors or cardiac infarction. This stiffness gradient 
3D hydrogel system can potentially be applied as scaffolds for the development of organoids for 
in vitro clinical testing.  
After performing multiple validation experiments, the team was able to show that the gelatin-
HPA hydrogel can be used to encapsulate cells in 3D, biocompatible environment, that it can 
create a range of in vivo stiffness levels through increased H2O2 concentration, and that it can be 
flowed through the microfluidic generator with cells to create a hydrogel with a continuous 
gradient in stiffness. However, due to limitations with time and resources the design can still use 
future refinement in order to enhance efficiency. The recommendations for future work are 
discussed in the next section.  
8.2 Recommendations for Future Work 
In the future, modifications should be made to improve the efficiency and accuracy of the 
gradient-hydrogel formation. Several of the major design challenges involved the consistency of 
gels when flowing the gradient generator multiple times, the incorporation of H2O2 without 
obstructive gelation occurring in the generator, the disruption of flow caused by air bubbles in 
the generator channels, and the clogging of generators after single use. 
Development of a more controlled flow system 
The current set-up for creating gradient-hydrogels through the gradient generator flow system 
has many factors that can introduce variability in the hydrogels that are formed. When setting up 
the system, the gel precursors must be prepared, thoroughly mixed in microcentrifuge tubes, and 
maintained at a temperature of 30 °C. The gradient generator and the tubing must then be 
prepared with water to remove any air bubbles prior to flowing the gel precursors. Once all 
equipment is prepped and in place, the H2O2 must be added at the same moment to each of the 
microcentrifuge tubes. This requires multiple personnel to work together. After the H2O2 has 
been added, the syringe pumps must be loaded, the air bubbles removed, and then the syringes 
must be locked in place to start flowing. In about 3 minutes, the gel precursors will have gelled, 
meaning that the aforementioned steps must completed efficiently in a timely manner. Even 
following the SOP for gradient-hydrogel formation, there are many steps that could introduce 
variability into the final gradient-gel. In the future, the development of a system with minimal 
steps, or more mechanically controlled steps, could help to better control the flow process and 
produce more consistent gradient-hydrogels. 
Downstream incorporation of H2O2 to improve gelation time 
The gelatin-HPA hydrogel formulas that were used for this project all had gelation times ranging 
from 3 to 10 minutes. These fast gelation times enable cells to be encapsulated in a 3D 
environment, however they cause the gradient generator to clog after about 3 minutes of flowing 
hydrogel precursors. A future modification that would enhance the efficiency of design would be 
to find a better method of incorporating the H2O2 downstream of the inlets. A new microfluidic 
mold could be designed where additional channels connect closer to the outlet where the 
gradient-hydrogel will be formed. This would allow more time to set up the whole flow system 
and could help to avoid clogging of the channels.  
Development of a heated platform to slow gelation time 
Another proposed method for preventing gelation of the hydrogel within the microfluidic 
channels is the development of a heated platform upon which the flow system can rest. Gelatin is 
thermoresponsive because it gels more rapidly at low temperatures. If the entire flow system 
were heated, then it is possible that the amount of time the hydrogel solution can be flowed 
without clogging the channels will increase. This would allow for easier handling of the hydrogel 
solutions during the flow process. 
Method for removing air bubbles from microfluidic channels 
One of the major limitations in creating a continuous gradient is the distortion of flow caused by 
air trapped within the gradient generator. The team tried removing air from the channels by 
increasing the flow rate to blast air out, flowing liquid through each inlet of the generator 
manually by syringe to push out bubbles, and by placing the generator in a liquid-filled dish 
under a vacuum. The most effective method of removal was to gently flow liquid through each 
inlet to prep the generator. However, bubbles were still noticeable in the system. After 
conducting research on methods currently used to remove air from microfluidic devices, the team 
recommends the incorporation of an air filter at the inlets of the generator. This would allow for 
any air to be filtered out of the generator as the precursors flowed through the inlet, and would 
aid in generating more consistent continuous gradients. 
Method for cleaning used generator molds 
The gradient generator is plasma bonded permanently to the glass coverslip covering the 
microfluidic channels. Ideally, each gradient generator mold should be able to be used 
repeatedly. However, by flowing the hydrogel precursors mixed with the H2O2 the microfluidic 
channels become clogged and are difficult to completely clean and sterilize. Finding the 
appropriate solvent to break the cross-links within the gelatin-HPA hydrogel will allow for 
molds to be reused. For this project, gradient generators were made out of PDMS and plasma 
treated each time the team needed to flow gradient-hydrogels. Finding a method to reuse the 
gradient generators will make the process more efficient by saving time and resources. 
Refined 3D cell encapsulation methods 
The procedure in Appendix D outlines the methods with which the 3D hydrogels were made. For 
the hydrogels formulated using the higher conjugate percentages (1.5% and 2%) and the higher 
H2O2 concentrations (2mM, 2.5 mM, 3mM, and 3.5mM), cells were consistently suspended 
throughout the 3D hydrogel. However, for the lower conjugate percentages (1% and 1.5%) and 
the lower H2O2 concentrations (1mM and 1.5mM) cells often sank to the bottom of the well 
before full gelation occurred. In order to accommodate for the longer gelation times of the lower 
concentration hydrogels, cells were added about a minute after the H2O2. Further exploration into 
the amount of time that should be waited after the H2O2 has been added will enhance methods 
for cell encapsulation in lower concentration hydrogels.  
Stiffness validation by rheometer 
AFM was used to measure the single stiffness of the gelatin-HPA hydrogels for this project. 
However, AFM measures the displacement of a cantilever tip on the surface of the hydrogel and 
can lead to high variation if the hydrogels are not completely uniform in stiffness. The gelatin-
HPA formula is dependent on chemical cross-linking, meaning that if the cross-linker is not 
thoroughly mixed then the stiffness could vary across the hydrogel. A rheometer could be used in 
the future to achieve more accurate single-stiffness baseline measurements. The rheometer 
destroys each sample that it measures, but it is capable of obtaining a stiffness measurement by 
coming in contact with the entire hydrogel. Using a rheometer could potentially provide more 
reproducible results and lower standard of deviations for baseline hydrogels.  
Stiffness gradient validation methods 
Due to time constraints, the team was unable to obtain stiffness measurements for a gradient-
containing hydrogel. However, the team has several suggestions for obtaining consistent 
measurements across the gradient. AFM is the recommended method for measuring the stiffness 
along the gradient, because it will enable sampling at specific points without destroying the 
sample. AFM is typically conducted on hydrogels adhered to glass coverslips. In order to 
measure the same areas of the gradient on different samples, the team suggests incorporating 
gridlines on the bottom of the coverslip. This would allow for known incremental measurements 
to be taken on every hydrogel in designated areas. Developing a standard method for stiffness 
validation of the gradient is crucial for obtaining reproducible results. 
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Glossary 
Atomic Force Microscopy A device used to assess stiffness. AFM consists of a cantilever 
tip that probes the specimen’s surface. Once it makes contact, 
the deflection is measured as a force. 
Conjugate A chemical compound that is formed by joining two or more 
compounds. 
Cross-link The covalent bond that forms to create networks within a 
hydrogel. 
Cross-linker A reagent or process that forms networks within a hydrogel. 
Extracellular Matrix The part of a multicellular structure that provides structural 
and biochemical support to surrounding cells. 
Gelatin Denatured form of collagen. 
Gelation time The amount of time it takes for a hydrogel to fully cross-link. 
Hydrogel Gel composed of one or more polymers suspended in water. 
Hydrophilic Hydrophilic refers to something that is “water-loving”. 
In Vitro Any process or reaction occurring outside of a living 
organism. 
In Vivo Any process or reaction occurring within a living organism.  
Microfluidics The controlled flowing of liquids at a micro-scale level. 
PDMS Polydimethylsiloxane (PDMS) is the most commonly used 
silicon-based organic polymer. It is often used to make molds. 
Polymer A substance with a molecular structure consisting of many 
repeating units bonded together. 
Rheometer A device used to measure the viscosity of samples that cannot 
be defined by a single value. Measures the response to applied 
forces. 
Stiffness An object’s rigidity or resistance to deformation in response 
to an applied force. 
  
Appendices 
Appendix A: Gantt Chart 
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 Literature review                     
 Write Introduction chapter                     
 Practice making hydrogels                     
 Develop hydrogel formula                     
 Finalize primary design & 
alternatives                     
 Write Background chapter                     
 Write Methods chapter                     
 Make hydrogel in lab                     
 Test hydrogel                     
 Analyze test results                     
 Revise design if necessary                     
 Write results                     
 Culture cells in hydrogel                     
 Perform assays                     
 Analyze cell response to 
stiffness                     
 Write Discussion chapter                     
 Write Final Presentation                     
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Appendix B: 6 Hats Method Exercise 
Blue Hat: The purpose of this assignment is to analyze design ideas for our MQP, “3D Hydrogel 
System with a Stiffness Gradient”, by applying various perspectives using the 6 Hats Method. 
Each perspective is intended to promote the development of new ideas that will lead to success 
and the generation of innovation. The order of the analytical process for this assignment is as 
follows: the white hat for objective reasoning, the green hat for creativity, the yellow hat for 
optimism, the red hat for emotion, and the black hat for critical thinking. All ideas will be 
recorded for later review and evaluation. 
White Hat: It is known that tissue-engineering scaffolds are commonly created using three-
dimensional hydrogels because their tissue-like environments are similar to what cells would 
encounter in vivo. Stiffness affects certain cell processes such as differentiation, proliferation, 
and morphology. Hydrogel scaffolds with stiffness gradients have been developed, but there 
currently is no method to create cell-encapsulating 3D hydrogels that contain continuous, wide-
ranging stiffness gradients. Stiffness within the body ranges from approximately 1kPa to 100kPa, 
a range that has not yet been completely represented within a single hydrogel. 
Green Hat: Various methods for gradient formation have been discussed. Gradients may be 
formulated using variations of polymer molecular weight or cross-linker concentration. Methods 
that have been considered include using syringe pumps to control flow rates and microfluidic 
molds. Particular mechanisms for gradient formation that could be applied to the project design 
are gravitational forces and diffusion. In research, chemical gradients have been made by 
physically adjusting test tubes to certain angles and allowing gravity to create a gradient. Perhaps 
this idea could be applied to develop a method for making precise stiffness gradients. Potentially, 
a microfluidic mold could be designed to incorporate diffusion of a cross-linker via channels into 
a polymer. 
Yellow Hat: By rapid prototyping a unique microfluidic mold, the appropriate dimensions can be 
used to allow for diffusion of a cross-linker to successfully penetrate the polymer. Ideally, this 
would produce a hydrogel, create a continuous stiffness gradient, and have high cell viability. 
This design would be beneficial by keeping the process of formation simple, and would avoid 
any conflict of premature polymer/cross-linker mixing. Whether the syringe pumps or the 
microfluidic molds are used, a standard operating procedure can be developed to create methods 
that allow identical hydrogels to be formed each time. 
Red Hat: It is most likely that using syringe pumps will be a complicated system. A microfluidic 
mold would be easier to use in comparison to programming syringe pumps alone. Using a 
microfluidic mold would be the easiest way to constrain the gradient formation to a highly 
controlled environment. Designing a unique mold to allow for diffusion to occur allows for more 
engineering design to be incorporated in the team’s project. The best choice would be to create 
our own mold to fit our desired specifications. It seems like designing the mold for diffusion 
takes a lot of research into porosity and diffusion coefficients. 
Black Hat: There are several complications that could arise during gradient formation. The shear 
forces of cells moving through a microfluidic mold or through piping from syringe pumps could 
compromise cell viability. It is possible that if gelation does not occur quickly enough that the 
cells will settle. If gelation occurs too rapidly, then the variations in either molecular weight or 
concentration may not mix appropriately for the creation of a continuous gradient to be 
successful. Diffusion is a difficult process to have precise control over, which could be a 
complication in developing a completely continuous stiffness gradient.  
  
Appendix C: SOP: Preparing Gelatin-HPA Conjugate 
Standard Operating Procedure: Preparing Gelatin-HPA Conjugate (200mL) 
Objective: To prepare the Gelatin-HPA conjugate that is used to create stiffness gradient-
containing hydrogels. This protocol will yield 200mL of conjugate prior to lyophilization. The 
procedure takes approximately 7 days to dialyze and lyophilize. 
Materials: 
60 mL N,N-dimethylformamide (DMF) 
53 L MilliQ water 
1.66 g (20 mmol) 3,4-Hydroxyphenylpropionic acid (HPA) 
1.6 g (27.8 mmol) N-hydroxysuccinimide 
1.91 g (20 mmol) 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide hydrochloride 
4.688 mg Gelatin 
140.256 g sodium chloride 
4 L Ethanol 
Scale 
Weigh boats 
Small beaker 
pH reader 
1 small, 2 medium magnetic stir bars 
2 stir/hot plate 
2 4 L beakers 
1 2 L capped beaker 
Parafilm 
Spectra/Por 6 dialysis tubing, 1K MWCO, 45mm flat width 
4 Standard dialysis tubing closure, 55mm width  
Scissors 
Spatula 
Forceps 
Liquid nitrogen bath 
Lyophilization flask 
Lyophilizer 
Autoclave 
 
Procedure: 
Day 1 
1. Prepare a 75 mL solution of 6.25 wt. % aqueous Gelatin in an autoclave-able container. 
(To do this, add 4.688 mg of Gelatin to 75 mL of MilliQ water. Do not mix.) 
2. Autoclave the Gelatin solution. Set aside for use later in protocol. 
3. Autoclave two 4 L glass beakers. Set aside for later use in protocol. 
4. Use a graduated cylinder to measure 60 mL of N,N-dimethylformamide (DMF).  
Carefully empty this amount to a small beaker.  
5. Add 90 mL of MilliQ water to the beaker from #4.  
6. Mix at medium speed for 3 minutes. 
7. Measure 125 mL from the DMF-water solution from #6 and pour into a fresh beaker. 
Dispose of the remaining original mixture. 
8. Add 1.66 g (20 mmol) 3,4-Hydroxyphenylpropionic acid (HPA) to solution from #7. 
9. Mix for 4 minutes. 
10. Add 1.6 g (27.8 mmol) N-hydroxysuccinimide and 1.91 g (20 mmol) 1-ethyl-3-(3-
dimethylaminopropyl)-carbodiimide hydrochloride to solution from #9. 
11. Mix the solution for 5 hours at room temperature, maintaining a pH of 4.7.  
12. Add the 75 mL (6.25 wt.%) aqueous Gelatin solution to the mixture from #11.  
13. Stir overnight (~12 hours) at room temperature and maintain a pH of 4.7. 
  
Day 2 
14. Prepare two 4 L beakers with 100 mM sodium chloride solution. (To do this, add 23.376 
g of sodium chloride to 4 L of MilliQ water. Mix until the sodium chloride dissolves 
completely.) 
15. Cut two 12 in. strips of the Spectra/Por 1000 Da molecular weight cut-off dialysis tubing. 
16. Fill a small beaker with distilled water, place the cut tubing inside, place a magnetic stir 
bar in the beaker, and place the beaker onto a stir plate for 20 minutes. 
17. Clamp the bottom of each tubing strip with a dialysis closure piece, leaving about an inch 
in length from the end of the tubing to the closure. 
18. Holding the tubing vertically with the clamp at the bottom, pipette 100 mL of conjugate 
into each dialysis tube.  
19. Clamp the top of the tubing with a second closure, leaving about an inch of empty space 
on both sides of the clamp. (There should be empty space inside the clamps to allow for 
influx of liquid.) 
20. Place each tube into its own 4 L beaker of sodium chloride solution.  
21. Place each 4 L beaker on a stir plate and set to slow speed.  
22. Cover the top of the beaker with Parafilm. 
23. After 16 hours, carefully remove the dialysis tubing. 
24. Empty the 4 L beakers and refill each with 23.376 g of sodium chloride and 4L of MilliQ 
water.  
25. Repeat steps 20-22. 
26. After an additional 16 hours, repeat steps 23-25.  
27. Continue dialysis for 16 more hours. 
 
Day 4 
28. After a total of 48 hours in the sodium chloride solution, remove the dialysis tubes from 
the 4 L beakers of sodium chloride. 
29. Empty the 4L beakers. 
30. Rinse the beakers with water. 
31. Pour 3 L of MilliQ water into each 4 L beaker.  
32. Carefully pour 1 L of ethanol into each 4 L beaker to prepare a mixture of 3:1 water and 
ethanol.  
33. Stir until solution is well mixed. 
34. Place each dialysis tube into a 4 L beaker.  
35. Place each 4 L beaker on a stir plate and set to slow speed.  
36. Cover the top of the beaker with Parafilm. 
37. After 16 hours, carefully remove the dialysis tubing from the beakers. 
38. Empty the 4 L beakers and refill each with 3L of MilliQ water and 1 L of ethanol.  
39. Repeat steps 34-36.  
40. Continue dialysis for 16 hours. 
 
Day 5 
41. After a total of 32 hours in the ethanol solution, remove the dialysis tubes from the 4 L 
beakers of water and ethanol.  
42. Empty the 4 L beakers. 
43. Rinse the beakers with water. 
44. Pour 4 L of MilliQ water into each 4 L beaker.  
45. Place each dialysis tube into a 4 L beaker.  
46. Place each 4 L beaker on a stir plate and set to slow speed.  
47. Cover the top of the beaker with Parafilm.  
48. After 16 hours, carefully remove the dialysis tubing from the beakers. 
49. Empty the 4 L beakers and refill each with 4 L of MilliQ water.  
50. Repeat steps 45-47. 
51. Continue Dialysis for 16 hours. 
 
Day 6 
52. After a total of 32 hours in the MilliQ water, remove the dialysis tubes from the 4 L 
beakers of water. 
53. Empty the 4 L beakers. 
54. Rinse the beakers with water. 
55. Gently wipe the outsides of the dialysis tubes to remove excess water. 
56. Pour the conjugate out of the dialysis tubes and into a lyophilization flask.  
57. Wearing gloves for protection, insert the lyophylization flask into the liquid nitrogen 
bath.  
58. Turn the flask so that it is almost horizontal and rotate it so that the conjugate freezes in a 
thin layer around the entire flask.  
59. Continue this process until no liquid conjugate remains within the flask.  
60. Attach the lyophilization flask to the lyophilizer. 
61. Lyophilize for 24 hours. 
 
Day 7 
62. Remove the flask from the lyophilizer. 
63. Use a spatula or forceps to remove the lyophilized conjugate from the flask and place into 
a 2 L beaker for storage.  
64. Store the lyophilized conjugate in the -2°C freezer until ready for use.  
Appendix D: SOP: Preparing Gelatin-HPA Hydrogels 
 
Standard Operating Procedure for Preparing Gelatin-HPA Hydrogels with Cells 
Objective: To prepare hydrogels using the Gelatin-HPA conjugate. This protocol can be 
followed to create 1, 1.5, and 2% gelatin-HPA gels at various stiffness levels. The hydrogels can 
be prepared to go in well plates, on coverslips, or in syringes. 
Materials: 
Lyophilized Gelatin-HPA 
10 U/mL horseradish peroxidase (HRP) 
DPBS (+) 
10X DMEM 
H2O2 (20, 30, 40, 50, 60, 70 mM) 
 
To prepare hydrogels: 
1. Dissolve gelatin-HPA powder in distilled H2O at 65°C to create a 3% weight stock 
solution. 
2. Pipette (40 μL, 60 μL, or 80 μL) 3% gelatin-HPA stock solution into a microcentrifuge 
tube. 
3. To #2, add 5µL of horseradish peroxidase at a concentration of 10 Units/mL. 
4. Add (45 µL, 25 µL, or 5 µL) of DPBS(+) to #3. 
5. Add 24 µL of cells suspended in 10X DMEM to #4. If not seeding the gel with cells, use 
plain 10X DMEM. 
6. To #5, add 6µL of H2O2 (20 mM, 30 mM, 40 mM, 50 mM, 60 mM, or 70 mM depending 
on desired final H2O2 concentration). For a control without H2O2, replace with 6 µL of 
DPBS(+). 
7. Immediately following step #6 pipette the solution up and down 4 times with a 100 µL 
micropipette to mix. Be careful not to create bubbles. 
8. If final gel is to be mounted onto a cover slip: 
1) Pipette 63 µL of final solution onto a gluteraldehyde-treated cover slip 
immediately after mixing. 
2) Place an APTMS treated coverslip on top. 
3) Allow to cross-link for 20 minutes. 
4) Pick up coverslips and gently slide the top coverslip apart from the bottom. 
5) Hydrogel should stick to the top coverslip. 
6) Place the hydrogel on the top coverslip into a petri dish. 
7) Cover the hydrogel with DPBS to hydrate. 
9. If final gel is to be added to a well plate: 
1) Pipette the appropriate amount per well by gently touching the pipette to the 
bottom of the well to ensure even spreading. 
2) Gently shake the plate to ensure full coverage of well. 
10. If final gel is to be loaded into syringe: 
1) Insert syringe fitted with luer-lock tip into the microcentrifuge tube. 
2) Slowly draw up the gel solution. 
3) Vigorously tap syringe to bring any air bubbles to the surface. 
4) Push air out of the syringe. 
 
Gelatin-HPA Hydrogel Formulas 
Reagents 1% 1.5% 2% 
1. Gelatin-HPA (3% Stock) 40 μL 60 μL 80 μL 
2. HRP (10U/mL) 5 μL 5 μL 5 μL 
3. DPBS (+) 45 μL 25 μL 5 μL 
4. 10X DMEM Cell Suspension 24 μL 24 μL 24 μL 
5. H2O2 6 μL 6 μL 6 μL 
 
H2O2 Stock Solutions 
Final H2O2 Concentration Stock Concentration 
1 mM 20 mM 
1.5 mM 30 mM 
2 mM 40 mM 
2.5 mM 50 mM 
3 mM 60 mM 
3.5 mM 70 mM 
Appendix E: Microfluidic Gradient Generators 
Preparation 
 
Standard Operating Procedure for Gradient Generator Preparation 
 
Objective: To prepare microfluidic gradient generators using PDMS. This procedure covers 
making negative molds from the silicone wafer and making duplicate molds from negatives.  
 
Negative Mold from Silicone Wafer: 
1. Weigh 70 g of silicone elastomer base into a weigh boat 
2. To #1 add 7 g of silicone elastomer curing agent and mix well. 
3. Place weight boat from #2 into a vacuum chamber and vacuum for 90 minutes to remove 
bubbles. 
4. Place silicone microfluidic wafer into a Petri dish. 
5. Pour the prepared PDMS around the sides and on top of the silicone wafer. 
6. Place the Petri dish from #5 into a 60°C oven for 1 hour. 
7. Once curing is complete, cut the PDMS out of the Petri dish in a rectangular shape 
around the silane-treated mold using a razor blade. 
8. Peel the new mold off the silicone wafer and place into a clean Petri dish. 
 
Duplicate Mold from PDMS Negative: 
1. Weigh 70 g of silicone elastomer base into a weigh boat 
2. To #1 add 7 g of silicone elastomer curing agent and mix well. 
3. Place weight boat from #2 into a vacuum chamber and vacuum for 90 minutes to remove 
bubbles. 
4. Place an inverse microfluidic mold into a Petri dish. 
5. Add 4 drops of silane to the Petri dish around (but not touching) the mold from #4. 
6. Place Petri dish from #5 inside a vacuum chamber set up inside a fume hood. Vacuum for 
45 minutes to allow silane to coat the PDMS. 
7. Once coated, transfer the silane-treated mold to a new, deeper Petri dish. 
8. Pour the prepared PDMS around the sides and on top of the silane-treated mold. 
9. Place the Petri dish from #8 into a 60°C oven for 1 hour. 
10. Once curing is complete, cut the PDMS out of the Petri dish in a rectangular shape 
around the silate-treated mold using a razor blade. 
11. Peel the new mold of the inverse mold and place into a clean Petri dish. 
    
  
Appendix F: Conducting AFM on Gtn-HPA 
Hydrogels 
 
Standard Operating Procedure for Preparing Gelatin-HPA Hydrogels for AFM 
 
Objective: To prepare the Gelatin-HPA hydrogels so that they can be measured for stiffness 
using AFM. This protocol reviews how to prepare the coverslips, make the hydrogel, and how to 
take the AFM measurements. 
 
Materials: 
25 x 25 mm coverslips 
1% APTMS solution 
.5% Glutaraldehyde solution 
Ceramic boat 
Forceps 
Aspirator 
AFM equipment 
Beaker 
DI water 
Chamber 
 
Preparing Top Coverslips: 
1. Oxygen plasma treat coverslips following protocol in Appendix G. 
2. Use forceps to place coverslips into ceramic boat. 
3. Mix 1.5 mL of APTMS in 150 mL of ethanol in a beaker to make a 1% solution. 
4. Place the ceramic boat into the beaker of 1% APTMS. 
5. Soak coverslips in APTMS for 3 minutes. 
6. Remove ceramic boat from beaker. 
7. Let coverslips dry for 3 minutes. 
8. Rinse coverslips with DI water. 
9. Aspirate the coverslip. 
10. Coverslip is ready to use. (Can be stored in refrigerator for a week) 
 
Preparing Bottom Coverslips: 
11. Follow steps 1-10 above. 
12. Mix 1 mL of 50% Glutaraldehyde in 100 mL of DI water to make a .5% solution. 
13. Fill a chamber with 50 mL of the .5% glutaraldehyde solution. 
14. Place coverslips into the chamber. 
15. Store in refrigerator for at least 4 hours before using. 
16. Remove coverslips. 
17. Aspirate. 
18. Coverslip is ready to use. (Can be stored in refrigerator for a week) 
 
Preparing Coverslips with Hydrogels: 
1. Mix together hydrogel precursors following the protocol outlined for the coverslip 
method in Appendix D. 
2. Let the cross-linked hydrogel hydrate in DPBS for 15 minutes. 
 
Conducting AFM: 
1. Conduct 3 measurements in 3 different points per hydrogel sample. 
 
  
Appendix G: Plasma Treating 
 
Standard Operating Procedure for Plasma Treating of Gradient Generator 
 
Objective: To attach a glass slide to a PDMS microfluidic gradient generator using plasma 
treatment. This will create a tight bond that will allow fluid to flow through the generator 
 
Microfluidic Preparation: 
1. Clean any dust off a PDMS gradient generator with a piece of scotch tape. 
2. Clean a glass slide using an ethanol then diH2O then ethanol rinse.  
3. Aspirate using air pressure.  
4. Remove any further dust using a piece of scotch tape. 
5. Place a glass slide so that it covers the well portion of the PDMS microfluidic mold. 
Leave the gradient tree exposed. 
 
Plasma Treating: 
1. Turn on AC red button. 
2. Open oxygen. 
3. Turn on the vacuum. 
4. Open up "plasma closed" valve by turning.  
5. Take out the cylindrical chamber gently, do not hit the bulb. 
6. Place the gradient generator and glass slide into the cylindrical chamber, then gently 
return the chamber to the plasma treatment machine. 
7. Turn the "level" knob to 50. 
8. Turn the "tuning" knob until a violet color appears. 
9. Turn the "level" knob to full power, it will cause a noise. 
10. Turn the "tuning" knob either direction until the noise stops. 
11. Plasma treat the gradient generator and glass slide for 45 seconds. 
12. Turn the "level" knob to 0. 
13. Turn of the vacuum and wait for the pressure to drop. 
14. Remove the cylindrical chamber and use tweezers to remove the microfluidic and the 
glass slide. Be careful not to touch the treated surfaces as it could ruin the plasma 
treatment. 
15. Peel off the glass slide and flip it so that the plasma treated side of the glass slide is flush 
against the plasma treated gradient tree portion of the PDMS mold. 
16. Gently press the glass slide and gradient generator mold together. 
 
  
Appendix H: Flowing Gradient-Hydrogels 
 
Standard Operating Procedure for Flowing Gradient-hydrogels 
 
Objective: To create a gelatin-HPA hydrogel with a continuous stiffness gradient. This protocol 
reviews how to prepare the microfluidic gradient generator for use and how to flow the system to 
create a gradient-hydrogel. 
 
Gradient Generator Preparation: 
1. Attach a glass slide to the generator according to the Standard Operating Procedure for 
plasma treating (Appendix G). 
2. Place gradient generator into a Petri dish under a microscope for better visualization. 
3. Cut three pieces of tubing to 23 cm long.  
4. Place a metal tip into one end of each piece of tubing.  
5. Place the tip of a luer-lock into the other end of each piece of tubing. 
6. Place the end of each metal tip into the three holes in the gradient generator mold. (Make 
sure the end of the metal tip reaches all the way down to the glass slide.) 
7. Using a syringe, fill each of the three tube and the gradient generator with DPBS(+). 
(This will remove air bubbles from the system.) 
 
Hydrogel Preparation: 
1. Follow the procedure from Appendix D to mix the hydrogel precursors for a final volume 
of 960 μL for the following concentrations: 
Gelatin-HPA Hydrogel Formulas for Gradient Generation 
 Gelatin-HPA 
Concentration 
H2O2 Concentration Dye Concentration 
Syringe 1 1.5% 1.5 mM None 
Syringe 2 2% 1.5 mM Low 
Syringe 3 2% 3.0 mM High 
 
2. Immediately after incorporating H2O2, load each of the three solutions into a syringe: 
1) Insert syringe fitted with luer-lock tip into the microcentrifuge tube. 
2) Slowly draw up the gel solution. 
3) Vigorously tap syringe to bring any air bubbles to the surface. 
4) Push air out of the syringe. 
3. Attach each of the three syringes to the luer-lock tips attached to the gradient generator 
setup. Arrange them in the following order: 1.5% with 3.0 mM on top, 2% with 1.0 mM 
in the middle, 2% with 3.0 mM on bottom. 
4. Load each of the three syringes into a syringe pump set at 15 µL per minute.  
5. Flow the system for 3-5 minutes until gelation occurs in the microfluidic well. Use a 
microscope for better visualization 
  
Appendix I: Gelation Time Data 
 
 1.0% Gelatin HPA 1.5% Gelatin HPA 2.0% Gelatin HPA 
1.0 mM H202 13.0 5.0 4.5 
1.5 mM H202 12.0 5.0 4.5 
2.0 mM H202 11.0 5.0 3.75 
2.5 mM H202 10.5 5.0 3.75 
3.0 mM H202 10.0 5.0 3.25 
3.5 mM H202 10.0 4.0 3.0 
 
 Gelation times of various concentration hydrogels measured in minutes. 
  
Appendix J: Atomic Force Microscopy Data 
 
First Run Baseline AFM Measurements 
 2% Gelatin-HPA 
H2O2 Conc. 
(mM) 0.9  1.35 1.8  
Avg Stiffness 
(Pa) 260,886 424 354 
St. Dev. (Pa) 237,402 143 199 
 
 
Second Run Baseline AFM Measurements 
 1.5% Gelatin-HPA 
H2O2 Conc. 
(mM) 1.0  1.5 2.0  
Avg Stiffness 
(Pa) 1,382,931 285 620 
St. Dev. (Pa) 2,548,988 382 308 
 
 
Third Run Baseline AFM Measurements 
 1.5% Gelatin-HPA 2% Gelatin-HPA 
H2O2 Conc. 
(mM) 1.5  2.0  2.5  3.0  3.5  1.5  2.0  2.5  3.0  3.5  
Avg 
Stiffness 
(Pa) 277 357 318 482 988 1,753 1,056 1,364 1.108 1,333 
St. Dev. 
(Pa) 140 89 87 452 856 651 560 484 352 531 
 
 
 
 
Fourth Run Baseline AFM Measurements 
 1.5% Gelatin-HPA 2% Gelatin-HPA 
H2O2 Conc. 
(mM) 1.0 1.5  2.0  2.5  3.0  3.5  1.0 1.5  2.0  2.5  3.0  3.5  
Avg 
Stiffness 
(Pa) 451 378 380 477 464 414 727 1,075 606 1,266 1,520 1,294 
St. Dev. (Pa) 84 103 49 215 141 109 428 707 393 214 1,315 181 
 
 
